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Abstract 
 
 Alternative splicing (AS) is the predominant mechanism responsible for 
increasing eukaryotic transcriptome and proteome complexity. In this phenomenon, 
numerous mRNA transcripts are produced from a single pre-mRNA sequence. AS is 
reported to occur in 95% of human multi-exon genes; one specific gene that undergoes 
AS is DNA polymerase beta (POLB). POLB is the main DNA repair gene which 
performs short patch base excision repair (BER). In primate untransformed primary 
fibroblast cell lines, it was determined that the splice variant (SV) frequency of POLB 
correlates positively with species lifespan. To date, AS patterns of POLB have only been 
examined in mammals primarily through the use of cell lines. However, little attention 
has been devoted to investigating if such a relationship exists in non-mammals and 
whether cell lines reflect what is observed in vertebrate tissues. This idea was explored 
through cloning and characterization of 1,214 POLB transcripts from four  
non-mammalian species (Gallus gallus domesticus, Larus glaucescens, Xenopus laevis, 
and Pogona vitticeps) and two mammalian species (Sylvilagus floridanus and 
 Homo sapiens) in two tissue types, liver and brain. POLB SV frequency occurred at low 
frequencies, < 3.2%, in non-mammalian tissues relative to mammalian (>20%). The 
highest POLB SV frequency was found in H. sapiens liver and brain tissues, occurring at 
65.4% and 91.7%, respectively. Tissue specific AS of POLB was observed in L. 
glaucescens, P. vitticeps, and H. sapiens, but not G. gallus domesticus, X. laevis and S. 
floridanus.  
 The AS patterns of a second gene, transient receptor potential cation channel 
subfamily V member 1 (TRPV1), were compared to those of POLB in liver and brain 
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tissues of G. gallus domesticus, X. laevis and H. sapiens. This comparison was performed 
to investigate if any changes (either increase or decrease) observed in the AS of POLB 
were gene specific or if they were tissue specific, in which case similar changes in AS 
would be seen in POLB and TRPV1. Analysis did not reveal an increase or decrease in 
both the AS of POLB and TRPV1 in either the liver or brain tissues of G. gallus 
domesticus and H. sapiens. This result suggested that the AS patterns of POLB were not 
influenced by tissue specific rates of AS. Interestingly, an increase in the AS of both 
genes was only observed in X. laevis brain tissue. This result suggests that AS in general 
may be increased in the X. laevis brain as compared to liver tissue.  
 No positive correlation between POLB SV frequency and species lifespan was 
found in non-mammalian tissues. The AS patterns of POLB in human primary 
untransformed fibroblast cell lines were representative of those seen in human liver tissue 
but not in brain tissue. Altogether, the AS patterns of POLB from vertebrate tissues and 
primate cell lines revealed a positive correlation between POLB SV frequency and 
lifespan in mammals, but not in non-mammals. It appears that this positive correlation 
does not exist in vertebrate species as a whole.  
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General introduction and thesis overview 
 
 The central dogma of molecular biology states that genetic information flows 
from deoxyribonucleic acid (DNA) to ribonucleic acid (RNA) to proteins (Crick 1970). 
Eukaryotic gene expression requires a regulatory stage called RNA splicing which 
involves the removal of introns and the ligation of exons to form messenger RNA 
(mRNA) (Darnell 1978). The mRNA then is processed through a step called translation 
to produce proteins. In the human genome, there are over 100,000 predicted proteins 
synthesized from an estimated 24,000 protein coding genes (Modrek et al., 2002). The 
phenomenon of alternative splicing is responsible for generating such a diverse array of 
proteins from only a limited number of mRNAs (Chow et al., 1977).  Alternative splicing 
can produce many different forms of transcripts from one gene, called splice variants, 
through the inclusion of different exons in the mRNA. Remarkably, in humans 95% of 
multi-exon genes undergo alternative splicing (Wang et al., 2008). In addition to 
generating protein diversity, the process of alternative splicing has been linked to gene 
regulation, gene expression, disease, and life history traits, such as lifespan (Taliaferro et 
al., 2011; Skandalis et al., 2010; Pan et al., 2008; Su et al., 2004; Yeo, et al., 2004).  
 A positive correlation between DNA polymerase beta (POLB) splice variant 
frequency and the lifespan of an organism was reported in primate untransformed 
fibroblast cell lines (Skandalis et al., 2010). Interestingly, POLB is a DNA repair gene 
(Singhal et al., 1993) and the POLB splice variants generated as a result of alternative 
splicing are proposed to be unproductive; in other words, they do not form functional 
proteins (Skandalis et al., 2004). Why would the production of non-productive splice 
variants of a DNA repair gene correlate positively with lifespan? Although the alternative 
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splicing patterns of POLB in mammals are well documented, with data collections 
compiled largely from human cell lines and several tissues (Skandalis et al., 2010; 
Simonelli et al., 2009; Skandalis et al., 2004; Thompson et al., 2002), little to no research 
has been focused on the alternative splicing patterns of POLB in non-mammals. Does a 
positive correlation between the alternative SV frequency of POLB and lifespan 
suggested in primates exist in non-primate mammals and in general in vertebrates? This 
thesis investigates said question by examining the alternative splicing of POLB in liver 
and brain tissues of six vertebrate species, four non-mammals and two mammals.  
 The first chapter is a literature review introducing RNA splicing, alternative 
splicing, POLB, the alternative splicing of POLB and the concept of lifespan as it relates 
to this work. This chapter provides the background necessary to investigate the 
correlation between alternative splicing of POLB and lifespan in vertebrates examined in 
Chapters Two and Three.  
 Various questions must be addressed before the subject of alternative splicing of 
POLB and lifespan in non-mammals can be discussed. Does POLB undergo alternative 
splicing in non-mammals? If so, what are the POLB splice variants types and their 
frequencies? Is the alternative splicing pattern of POLB tissue specific in these species? 
Could these patterns be influenced by an overall increase in alternative splicing in a 
specific tissue type? How do the alternative splicing patterns of POLB compare to other 
genes in the same tissues? Does a positive correlation between POLB splice variant 
frequency and lifespan exist in non-mammals? Chapter Two will address these questions 
through the characterization of over 840 POLB in non-mammalian tissues. 
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 Chapter Three compares the alternative splicing of POLB in mammalian tissues to 
those described in primate untransformed fibroblast cell lines (Skandalis et al., 2010). 
This comparison is essential to investigate whether the alternative splicing of POLB in 
tissues reflects that observed in cell lines. A detailed description of the alternative SV 
frequency of POLB and the types of splice variants in human, rabbit liver and brain 
tissues are documented for the first time. Finally, in conjunction with the alternative 
splicing patterns of POLB in mammals, non-mammals and cell lines, the possibility of a 
positive correlation between POLB splice variant frequency and lifespan in vertebrates 
will be explored.  
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CHAPTER ONE: Literature review 
RNA splicing  
 
 Eukaryotic genes are composed of introns and exons. Introns include any 
sequence removed from the final RNA transcript, referred to as the mature messenger 
RNA (mRNA). Exons are defined as any sequence left in the mRNA. Before the RNA, 
termed as precursor-mRNA (pre-mRNA) can be used to make proteins, intronic 
sequences must be cut out. Once the introns are removed and exons are ligated together, 
mRNA is formed and protein synthesis takes place. The process of intron removal is 
termed RNA splicing and is carried out by the spliceosome (Zhou et al., 2002).  
 The spliceosome functions to recognize introns and exons in order to form the 
correct mRNA. The major eukaryotic spliceosome is a multimegadalton 
ribonucleoprotein (RNP) complex comprised of five small nuclear RNAs (snRNAs) (U1, 
U2, U4, U5 and U6) and numerous proteins (Wahl et al., 2009).  These five snRNAs 
assemble with their associated proteins to form small nuclear ribonucleoproteins 
(snRNPs). Once assembled the spliceosome must be able to recognize introns and exons. 
This recognition is enabled by four conserved signals, 5’splice sites (5’SS), 3’ splice sites 
(3’SS), the branch site (A), and the polypyrimidine tract (PPT) (Figure 1.1) (reviewed by 
Keren et al., 2010). The 5’ SS is also called the donor site and is located at the 5’ end of 
the intron. The conserved nature of this site, comprosed of a guanine (G) followed by a 
uracil (U), facilitates recognition. The 3’ SS, also called the acceptor site, is located at the 
3’ end of the intron and is denoted by an adenine (A) followed by a guanine (G). The PPT 
is approximately 15-20 nucleotides long and rich with pyrimidine nucleotides, usually 
uracils. This sequence is located 5-40 base pairs before the 3’ end of the intron (Wagner 
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et al., 2001). Upstream from the PPT is the branch site which is an A residue. The 
spliceosome catalyzes the two transesterification steps required for proper RNA splicing. 
In the first step the 2’hydroxyl group of the branch site attacks the phosphate at the 5’SS. 
Ligation of the 5’end of the intron to the branch site results in a detached 5’ exon and an 
intron-3’ exon fragment. Next, the phosphate at the 3’ end of the intron is attacked by the 
3’hydroxyl of the detracted exon. The result of this attack is the ligation of the two exons 
and removal of the intron which was in between (Black, 2003).  
 Splicing can be enhanced or silenced through the binding of auxiliary proteins to 
additional sites within exons and introns. Examples of such proteins include 
serine/arginine (SR) proteins, heterogeneous nuclear ribonuclear proteins (hnRNPs), and 
polypyrimdine tract-binding (PTB) proteins. These proteins can recognize binding sites 
consisting of short degenerate sequences located within exons and introns. There are four 
major sites, two which result in splicing enhancing and two for splicing silencing. Exons 
can contain exonic splicing enhancers (ESEs) or exonic splicing silencers (ESSs) and 
introns can contain intronic splicing enhancers (ISEs) or intronic splicing silencers (ISSs) 
(Keren et al., 2010). ESEs are commonly located in constitutive exons as opposed to 
alternatively spliced exons (Black 2003). Both of these types of exons can be involved in 
a process called alternative splicing (AS).  
 
 
Figure 1.1 Splice signals within pre-mRNA transcripts.  
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Alternative Splicing  
 
 Almost immediately after the discovery of RNA splicing, it was determined that 
numerous mRNA transcripts could be produced from one pre-mRNA sequence (Roger 
and Sharp, 1977). This phenomenon was termed alternative splicing (AS) and it's 
importance was not immediately recognized. The significance of AS was initially 
underestimated, as it was thought to only affect a few human genes such as mammalian 
immunoglobuins and T-cell receptors. AS is now considered to be one of the major 
mechanisms for generating protein diversity, and is observed in metazoan, fungal, and 
plant genomes (Artamonova et al, 2007). Perhaps one of the most famous examples of 
AS can be seen in the Drosophila melanogaster gene Down syndrome cell adhesion 
molecule (Dscam), which can generate 38,016 distinct mRNA isoforms, a number far in 
excess of the total number of genes (~14,500) in the organism (Graveley, 2004). AS of 
human genes is extremely common (Pan et al., 2008). In fact, 95% of all human multi-
exon genes are alternatively spliced (Wang et al., 2008). There are several ways a pre-
mRNA sequence can be alternatively spliced (as reviewed by Modrek et al., 2002) and 
there are four main subgroups of AS events outlined below (Figure 1.2).  
 The four main subgroups of AS events are exon skipping, alternative 3’SS 
selection, alternative 5’SS selection and intron retention. The most common of these AS 
events seen in mammals is exon skipping (Sugnet et al., 2004). Exon skipping occurs 
when an exon, termed a cassette exon, and its flanking introns are spliced out and not 
included in the mRNA transcript. A cassette exon is either retained in the mRNA or 
alternatively used during AS (Graveley 2001). A plausible cause of this AS event is the 
inhibition of an exon inclusion signal located within the cassette exon itself (Van Ommen 
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et al., 2011). Alternative 3’SS and 5’SS selection is observed when two or more splice 
sites are recognized at one of the ends of an exon. This type of AS event occurs when two 
competing splice sites are present. The effect of competing 5’SS selection was 
demonstrated with a splicing factor call splicing factor 2 (SF2). SF2 is a 33 kDa protein 
that binds nonspecifically to RNA. Different concentrations of SF2 have a profound 
effect on a model pre-mRNA substrate that contains two competing 5’SS and only one 
3’SS. If SF2 is in low concentration the outside 5’SS is used. In contrast, when SF2 is in 
high concentrations the inside 5’SS is used (Kranier et al., 1990).  The competition 
among multiple splice sites has been linked to splicing silencers and enhancers (Nilsen et 
al., 2010). Furthermore, intron retention is the fourth and rarest type of AS event seen in 
vertebrates. It is characterized by an intron remaining in the mRNA transcript. By 
convention, when an in intron is left in the mRNA it is referred to as an exon. A recent 
example of intron retention was found in the stress axis-regulated exon (STREX)-
containing a calcium-activated big potassium channel gene. In rat hippocampal cells it 
was discovered that splice variant expression was regulated by intron retention (Bell et 
al., 2010). In addition to these four major subgroups of AS events, there are less frequent 
types including mutually exclusive exons, alternative promoter uses and alternative 
polyadenylation (Keren et al., 2010). There are several models to describe how these AS 
events are regulated which are outlined here (Figure 1.2).  
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Figure 1.2 Types of AS events. The four main subgroups of AS that are seen in 
vertebrates. Grey boxes represent exons and black lines/boxes represent introns. Dashed 
lines show the splicing pattern observed in the respective type and dotted lines 
demonstrate the predicted splice site.  
Regulation of AS 
 
 Several factors affect splicing patterns (Mata et al., 2011; Luco et al., 2001) 
including transcription rate, core-splicing-machinery, intron size and competition 
between splice sites (Nilsen et al., 2010).  
 Three of the major models of how AS is regulated will be presented here. The 
first model presented here involves the kinetic effect of splicing silencers on AS and 
explains regulation in terms of SS competition (Yu et al., 2008). As previously discussed, 
this model applies to mRNA transcripts in which an exon contains two or more splice 
sites. In cases where no ESS is present the appropriate spliceosome components will bind 
to the nearest 5’SS of the two SSs present in respective the exon. Alternatively, if the 
silencer is present in the exon the rate at which the first 5’SS is used is decreased 
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promoting the splicing of the distal 5’ SS. When there is no competing 5’ splice site 
upstream the presence of a silencer does not affect the rate of splicing (Yu et al., 2008).  
 Another model of AS regulation describes the impact of interplay between 
transcription elongation rate, chromatin structure and histone modification on AS (Alló et 
al., 2009). Take for example a multiple exon gene that contains both constitutively 
transcribed exons and one alternative exon. The constitutive exons are packaged into 
nucleosomes which always contain a histone that is trimethylated at the lysine residue 36 
(Alló et al., 2009). Nilsen et al. (2010) proposed that when the RNA polymerase and the 
spliceosome transcribe a gene it travels over the alternative exon very quickly and that 
the exon does not become attached to the RNA complex and is not included in the mature 
mRNA. When the alternative exon is packaged into a nucleosome containing a histone 
that is trimethylated at the lysine residue 36 the processivity of the RNA polymerase is 
slowed. The alternative exon is captured and included in the mRNA transcript (Nilsen et 
al., 2010). This model agrees with the results found in a study by Alló, M. et al. (2009) in 
which an induced change in chromatin structure led to a reduction in transcription 
elongation complex ability and changes in AS patterns. Nilsen et al. (2010) explain that 
this model requires more investigation with particular regards to whether transcription 
rates would differ between tissues with high or low levels of AS using this model.  
 Finally, the third model for AS regulation is the Kinetic model of the mutually 
exclusive splicing of pre-mRNA (Neves et al., 2004). This model has been investigated 
primarily in the Dscam gene of Drosophila, previously mentioned to encode for more 
than 38,000 mRNA isoforms. This gene contains 48 alternative exonic sequences and 
determination of which exons are spliced depends on competition between RNA 
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secondary structures for a single docking site, one site selector sequence in each of the 48 
exons and various other proteins (Nilsen et al., 2010; Schmucker et al., 2000). 
 In addition to these AS regulatory mechanisms nonsense mediated decay (NMD) 
can also play an important role in AS (Lewis et al., 2003). NMD is a quality control 
mechanism which functions to selectively degrade mRNAs that have premature 
termination codons (PTCs) in the transcript in eukaryotic cells (Hwang et al., 2011). This 
mechanism prevents truncated proteins from being translated, which can have negative 
effects (Chang et al., 2007). In humans it was found that one-third of splice variants 
contain PTCs. Although all of these transcripts theoretically should be subject to NMD 
this is not the case. There are numerous splice variants known to regulate protein 
expression that are not subject to NMD (Lewis et al., 2003). A recent study showed that 
NMD coupled with AS regulates the expression of the human short stature homeobox 
(SHOX) gene.  AS of the SHOX gene causes an inclusion of the alternative exon 2a. This 
exon 2a transcript leads to NMD in turn altering the expression of SHOX in a tissue and 
time specific manner (Durand et al., 2011). As is the case with SHOX, it is common to 
find genes that are alternatively spliced in a tissue specific manner (Boue et al., 2006).  
Tissue specificity and alternative splicing  
 
 Numerous AS events have been shown to be tissue specific in a variety of 
vertebrate species (Venables et al., 2012; Su et al., 2004; Yeo, et al., 2004). Tissue 
specific AS refers to both the proportion of alternative transcripts and the types of 
alternative transcripts produced. In some genes tissue specific AS is suggested to regulate 
gene expression by generating tissue specific transcripts, altering gene function, co-
regulating other genes, influencing differentiation of tissues, and controlling fundamental 
24 
 
mechanical properties of certain tissues (Taliaferro et al., 2011, Pan et al., 2008, Su et al., 
2004, Yeo, et al., 2004).  
 Tissue specific AS can be regulated by proteins which are themselves tissue 
specific (Kim et al., 2011). One example of this is the mammalian Fox 1 family (Fox) of 
proteins, which consist of Fox-1, Fox-2 and Fox-3. These proteins contain almost 
identical RNA recognition motifs that bind to the RNA element 5'-UGCAUG-3' and 
regulate alternative splicing. Fox-1 is only expressed in brain and striated muscles 
whereas Fox-2 is expressed in numerous tissues and Fox-3 produced exclusively in 
neural tissues. Not only do these different Fox proteins regulate AS of other genes in their 
respective tissues but different isoforms of the proteins have also been shown to have 
unique subcellular expression and an effect on splicing (Kim et al., 2011).  
 Tissue specific AS has been best described in mammals, most notably in humans 
and mouse transcriptomes (Su et al., 2003). Although recent studies investigating this 
phenomenon have been extensive, the available data demonstrate differences in tissue 
specific AS patterns. These differences are largely due to the method used to examine 
tissue specific patterns of AS. For example, one study analyzed splicing patterns in 
humans using expressed sequence tags (ESTs) gathered from cDNA libraries from 
different tissues (Yeo et al., 2004). This study gathered the data based on distinguishing 
between the different AS events exon skipping and alternative 5’SS or 3’ SS using a large 
scale computational analysis from approximately two dozen human tissues (Yeo et al., 
2004).  This analysis did not consider intron retention AS events which may have led to 
an underestimation of AS. Pan et al. (2008) current mRNA sequence datasets consisting 
of 17-32 million 32-nucleotide-long reads in seven normal human tissues to investigate 
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tissue specific AS patterns. In contrast to the methods employed in the study by Yeo et al. 
(2004), Pan et al. (2008) based their measurements for alternative splicing levels on 
splice junction sequences that represent known and hypothetical splicing events. 
Although these studies use different methods of investigation they have provided 
valuable information about AS tissue specificity. It is difficult to maintain consistency 
throughout these types of studies for various reasons. For example, when determining AS 
levels in tissues using ESTs and mathematical models certain types of splicing events are 
ignored or hypothetical splicing events are included. These factors could result in an 
under or over estimation of the actual AS levels in a tissue. Additionally, utilization of 
large databases, such as GenBank, only allow for the splicing events which have been 
recorded to be included in large scale studies. This could cause underestimation of AS 
levels (Koralewski et al., 2010).  
 In humans, liver and brain tissues showed the highest levels of AS (Pan et al., 
2008; Yeo et al., 2004). Yeo et al. (2004) reported these levels to be 42% in the liver and 
39% in the brain. This study showed other tissues were determined to have a proportion 
of alternative splice genes at 35% (testis), 28% (lung), 27% (kidney), and 26% (placenta). 
The lowest levels of AS were found to be in the uterus and muscle at 15% for both tissues 
(Yeo et al., 2004). This data was gathered using ESTs derived from cDNA libraries from 
described tissue types. The splicing events considered in this study were exon skipping 
and alternative 5' / 3' SS while intron retention was not considered (Yeo et al., 2004).   
 Tissue specific exon skipping and SS selection within skipped exons were 
investigated in the study conducted by Yeo el al. (2004). Human liver was reported to 
produce the highest number of genes with alternative 3’SS exon AS events at 17%, 
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followed by the brain at 11% and lastly breast tissue at 4% (Yeo et al., 2004). 
Additionally, the tissue which produced the highest number of genes with skipped exons 
was the brain at 26%, followed by the testes at 23% and ovary tissue at 10% (Yeo et al., 
2004).  
 The high proportion of AS events in the liver and brain of humans may be 
necessary for the differentiation of these tissues. Splicing factors present in these tissues 
also could be affecting the tissue specific levels of AS seen (Yeo et al., 2004).  
Alternative splicing in non-mammalian vertebrates 
 
 ESTs or mRNA analysis on whole organism AS rates of non-mammalian 
vertebrates have been performed and the results are varied (reviewed by Kim et al., 
2006). For example, a study by Brett et al. (2002) estimated that across metazoan 
organisms the rates of AS are similar. In comparison, a study by Kim et al. (2004) 
suggested that AS rates are higher in mammals compared with invertebrates. The AS rate 
in chickens is perhaps the most well documented non-mammalian vertebrate species 
reported (Kim et al., 2004). In chickens the percent of whole organism AS is estimated to 
be 42%, the highest recorded non-mammalian vertebrate species rate determined thus far 
(Artamonova et al., 2007; Kim et al., 2007). These results were gathered from 139 
chicken ESTs libraries, which included all available tissue types, including embryonic, 
and cell lines. Kim et al. (2007) reported no cell line or tissue specific AS in chickens 
(Kim et al., 2007). Using available ESTs, it was determined that out of 162 AS events 
which can occur in mammals, only 37 (22.9%) were present in frog species (Mudge et al., 
2011).  
27 
 
 To date, no large scale analysis of tissue specific AS in non-mammalian 
vertebrates has been conducted. Present studies that have investigated tissue specific AS 
in these species are gene specific. For example, Venables et al. (2012) showed 4 Fox-
regulated exons were spliced in a tissue-specific manner in muscle and heart tissues of 
Xenopus laevis. In chickens, Musclebind-like (MBNL) proteins MBNL1 and MBNL2 
were shown to have alternatively spliced isoforms which were highly tissue specific to 
heat tissue (Terenzi et al., 2010). Tissue specific AS was demonstrated in the lizard (H. 
Suspectum) when two alternatively spliced proglucagon mRNA transcripts were found to 
only be expressed either in the lizard pancreas or intestine tissues (Chen et al., 1997).  
Function of unproductive transcripts 
 
 Large scale EST studies show splice variants of various genes produced in 
different tissues and cell types in many species (McManus et al., 2011; Xu et al., 2002). 
Some of these SVs do produce functional proteins (reviewed by Nilsen et al., 2010; 
Lareau et al., 2007). For example, a recent study showed that in human embryonic stem 
cells (ESC) the AS of the Forkhead box protein P1 gene, FOXP1, produced functional 
proteins (Gabut et al., 2011). FOXP1 is a transcription factor that regulates a number of 
genes involved in cell proliferation, differentiation and development (Nakae et al., 2003).  
When the canonical transcript of FOXP1 is translated, a reduced expression of 
pluripotency genes and an increase expression of differentiation genes were observed. 
Alternatively, when exon 18a was included in FOXP1 mRNA transcript it was termed 
FOXP1-ES and produced a longer protein. FOXP1-ES preferentially binds to specific sets 
of DNA sequences that are not bound by FOX-P1. Binding of these sequences promotes 
expression of transcription factors which repress ESC differentiation (Gabut et al., 2011). 
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FOXP1 and FOXP1-ES are just one example of how AS produces functional proteins. 
However, many transcripts that are generated fail to do this. In fact, it is proposed that the 
majority of alternatively spliced mRNAs do not produce functional proteins (Skandalis et 
al., 2004; Sorek et al., 2004). Many unanswered questions remain, including the purpose 
of these alternatively spliced transcripts if not to encode for functional proteins. We must 
ask whether these unproductive transcripts are essentially "non-functional" or do they 
have a function outside of protein production?  
 One hypothesis proposes that these alternately spliced mRNAs, although not 
producing proteins, are functional because they are required during the life cycle of an 
organism and are activated in a regulatory manner (Sorek et al., 2004). Sorek et al. (2004) 
proposed this hypothesis based on the investigation of conserved alternatively spliced 
events between human and mouse genomes. Taken together, a new definition of a 
functional mRNA transcript has been put forth as one that is required during the life cycle 
of an organism and is activated in a regulatory manner (Sorek et al., 2004).  Additionally, 
some unproductive transcripts are highly conserved throughout evolution (Iida et al., 
2006; Nern et al., 2005).  This implies that these transcripts may play a significant role in 
gene regulation (Nilsen et al., 2010; Skandalis et al., 2010; Artamonova et al., 2007; 
Lewis et al., 2003). For instance, in humans the gene encoding the ribosomal protein L3 
(rpL3), a protein that binds to specific HIV-1 RNA, is alternatively spliced (Bannwarth et 
al., 2005). The splice variant produced contains an in-frame PTC and is subject to NMD. 
When canonical rpL3 is overexpressed the level of SVs increases. This increase triggers a 
negative feedback loop that signals for a decrease of the canonical rpL3. The splice 
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variant of rpL3 does not encode for a functional protein therefore indicating that AS of 
this gene regulates its own canonical expression (Cuccurese et al., 2005).  
 It is difficult to determine the function, if any, in all SVs produced from AS. Even 
in terms of one specific SV of a gene, we must investigate possible functions independent 
of protein synthesis. An investigation such as this would have to look at the splice 
variant's involvement in regulatory pathways at all stages of an organism's development 
(Skandalis et al., 2010). Predictions on how to determine whether a SV has a function 
have been developed to address this issue.  
 The symmetry of an exon is a good start to determine if a variant has function. If 
an exon is symmetrical, i.e. that is it can be divided by three, the insertion of this exon in 
a transcript will not disrupt the reading frame. Maintenance of the reading frame may 
indicate that the transcript could form a functional protein. Alternatively, transcripts that 
do have a PTC due to AS, may activate the NMD mechanism. The search for 
functionality of these transcripts can now be narrowed. NMD activation may indicate a 
negative feedback loop, as seen in the rpL3 gene regulation (Cuccurese et al., 2005).  
 The evolutionary conservation of a SV is another good indication of possible 
function (Keren et al., 2010; Skandalis et al., 2010; Lemaire et al, 2004).  One study 
proposes evolutionary conservation in the AS of the fission yeast phosphatidate 
cytidylyltransferase (CDS1) and its human homolog CHK2 genes. The proteins encoded 
by these genes play a role in responding to DNA damage at a cell checkpoint. Both CSD1 
and CHK2 produce SVs with a frame shift in the open reading frame due to a PTC. It is 
proposed that these variants act as dominant negatives that play a role in the DNA 
damage response.  Since this variant is found in both yeast and humans in the respective 
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homologs it has been suggested that this is evidence of an evolutionary conservation AS 
mechanism (Lemaire et al, 2004).  
 Another example of evolutionary conservation of AS is observed in the DNA 
polymerase beta gene, POLB. Skandalis et al. (2010) reported that the AS of POLB is 
conserved in primary untransformed fibroblast cell lines of five primate species. The 
study revealed that one particular SV, exon two skip, was found to be conserved 
throughout all species investigated (Skandalis et al., 2010). This SV does not produce a 
functional protein (Simonelli et al., 2009), however, it is still conserved among 
mammalian species. The AS of POLB is the focus of this thesis and will be discussed in 
detail.  
DNA Polymerase Beta (POLB) 
 
 DNA Polymerase Beta (POLB) is a highly conserved, constitutively expressed 
protein involved in DNA repair (Sawaya et al., 1994). Belonging to the Pol X-family 
species of proteins, POLB is believed to be expressed in the genomes of all vertebrates as 
a DNA directed DNA polymerase (Uchiyama et al., 2009). POLB is the main enzyme 
which performs a type of repair called base excision repair (BER), also called gap-filling 
DNA synthesis (Thompson et al., 2002; Sobol et al., 1996). Specifically, POLB is 
performs short patch BER, which replaces single nucleotides mistakes but it has been 
reported to repair gaps up to six nucleotides (Idriss et al., 2001). In order to do this, 
POLB uses alkaline phosphatase lyase activity to remove the 5’ phosphate of the 
mismatched nucleotide and will add one nucleotide to the 3’ end of the gap (reviewed in 
Parsons et al., 2011). When DNA damage is detected, POLB, which is normally located 
in the cytoplasm, will translocate to the nucleus. POLB is a monomeric 335-amino-acid, 
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39-kDa polymerase containing two distinct functional domains (Idriss et al., 2002; 
Abbotts et al., 1988).  The first domain, the 8 kDa amino-terminal has DNA binding and  
lyase activity (Idriss et al., 2002). The second is the 31 kDa carboxyl-terminal domain 
that functions as the catalytic, also called the polymerase, domain (Simonelli et al., 2009). 
The catalytic domain contains finger, palm and thumb subdomains which have double 
stranded DNA binding, nucleotidyl transferase and dNTP selection activities, 
respectively. These domains and respective subdomains are encoded by four proteolytic 
domains which correspond to specific exons of the POLB gene (Idriss et al., 2002).  
 Fourteen constitutive exons encode for the single copy POLB gene located on 
chromosome 8p11.2 (NCBI). Exons 1-4 encode for the single stranded binding 
deoxyribosephosphate (dRP) lyase catalytic activity which allows POLB to process the 
5’-phosphate at the end of the gap. Exons 5-7 encode for the double stranded DNA 
binding domain and exons 8-11 encode a domain that deal with the nucleotidyl 
transferase activity. Finally, dNTP selection activity of POLB is encoded by exons 12-14 
(Idriss et al., 2002). The mRNA sequence conservation of POLB is high among 
vertebrates. A Basic Local Alignment Search Tool (BLAST) shows that compared to 
human POLB mRNA, primate species exhibit >90% nucleotide sequence identity. Other 
vertebrate species POLB mRNA sequence identity percents compared to humans are the 
domestic dog (92%), the giant panda (92%), the red panda (99%), the African bush 
elephant (93%), bovine (90%), wild boar (90%), the Chinese hamster (89%), the house 
mouse (88%), the chicken (80%) and the African clawed frog (76%). All constitutive 
exons are the same size (number of bps) for the canonical POLB mRNA sequences for all 
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species mentioned here however the genomic DNA shows various size differences in 
introns.  
Alternative splicing and POLB 
 
 POLB is subject to AS (Bhattacharyya et al., 1999). Studies involving 
investigation of POLB AS patterns have been primarily carried out in humans. However, 
such splicing has been examined in other mammalian species including primates, cows, 
sheep, red pandas, dogs, rats and mice, to a lesser extent (Skandalis et al., 2010, 
Simonelli et al., 2009, Thompson et al., 2002, Skandalis et al., unpublished). A common 
theme in all these studies has been that AS of POLB occurs in high frequency in these 
species. POLB commonly produces alternatively spliced transcripts, also called splice 
variants or non-canonical transcripts. As seen in humans cell lines the production of 
POLB splice variants were at higher frequencies than the canonical transcript (CT) (CT: 
42.6%) (Skandalis et al., 2010). Similar rates were found in normal human bladder tissue 
and normal bladder cell lines (Thompson et al., 2002). Skandalis et al. (2010) report other 
primate POLB SV frequencies as 52.3 % (Pongo pygmaeus), 30.7% (Gorilla gorilla), 
26.1% (Pan troglodytes) and 12.4% (Macaca fascicularis).  
 The types POLB SVs have also been investigated (Skandalis et al., 2010; 
Simonelli et al., 2009; Disher et al., 2007; Skandalis et al., 2004; Thompson et al., 2002). 
To date, the most common POLB SV found in mammals is the loss of exon two (∆2).  
POLB ∆2 SV is not translated and does not produce a functional protein (Disher et al., 
2007, Simonelli et al., 2009). When exon two is lost a premature termination codon 
(PTC) is created in exon three and results in a truncated 26 amino acid protein. This 
truncated POLB protein would only contain a portion of the single stranded DNA binding 
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dRP lyase domain. The function of this splice variant is not yet known although it has 
been proposed that it may provide a microRNA precursor or act as a dominant negative 
regulator of normal POLB activity (Skandalis et al., 2010; Thompson et al., 2002).  The 
other common POLB splice variants found in humans, in order of prevalence, are loss of 
exon 11, inclusion of exon α, and loss of exon 4 (Skandalis et al., 2010). Other primates 
show numerous other SVs in addition to the common ones seen in humans. For example, 
Pongo pygmaeus has the second highest POLB SV frequency after humans (Skandalis et 
al., 2010).  
 The majority of the SVs recorded in primates were complex multiple exon loss 
(Skandalis et al., 2010). These SVs consistently had an exon two loss accompanied by a 
loss of either exon 11, exon 13, exons 12 and 13, exons 3-6, exon 5, exons 3-9, or exon 3-
5 and 13. Seven of these splice variants were unique to other non-human primate species, 
despite the 99% mRNA sequence identity with humans. Complex intron retention and a 
loss of exon(s) splicing events were also found in some primate species (Skandalis et al., 
2010). All data gathered from non-human primate species were collected from 
untransformed fibroblast cell lines. There are reports that these splicing events are not 
limited to cells lines and in fact are found in normal human tissues as well (Thompson et 
al., 2002).  
 The comparison of SV frequencies and types in cell lines versus tissues is further 
addressed in Chapter Three. In addition to normal human cell lines and tissues, diseased 
samples have also been investigated with regard to POLB AS.  
Alternative splicing of POLB and disease 
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 The AS of POLB has been linked to disease (Starcevic et al., 2004; Thompson et 
al., 2002; Bhattacharyya et al., 1999). POLB SVs have been identified in various types of 
human cancers including breast, lung, bladder, gastric, lung, and brain cancer (Simonelli 
et al., 2009; Thompson et al., 2002; Bhattacharyya et al., 1999; Chyan et al., 1996). The 
two most common SVs observed have exon two skip or exon 11 skip (Simonelli et al., 
2009; reviewed by Sweasy et al., 2005). It has been suggested that a loss of exon 11 
results in a loss of important repair functions in cells (Bhattacharyya et al., 1997). For 
example, Bhattacharyya et al. (1997) showed that HeLa cells transfected with POLB ∆11 
variants had significantly reduced BER activity. This decrease in BER activity would 
result in increased amounts of DNA damage and an increase in mutations. It has been 
suggested that a mutator phenotype could be the result if these mutations occur in genes 
that normally maintain of genetic stability, like ras, p53 and Rb (Bhattacharyya et al., 
1997). First proposed by Loeb, the mutator phenotype is an early step in tumour 
progression (Loeb 2001). This was further supported by a review of small scale studies 
and it was found that 30% of human tumours express POLB SVs (Sweasy et al., 2004).  
 POLB SVs leading to reduced BER and mutations in cancer related genes are not 
the entire story. Studies have shown that an over expression of canonical POLB 
transcripts were elevated in breast, colon, prostate cancers, and gastric tumours (Tan et 
al., 2004; Srivastava et al., 1999).  It has been suggested that this increased expression is 
a result of tumours having higher levels of DNA damage and requiring more functional 
POLB for repair (Srivastava et al., 1998). Other authors proposed that high levels of 
POLB destabilize further cellular processes and in turn lead to tumour progression 
(Sweasy et al., 2003).  
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Alternative splicing of POLB and lifespan  
 
 A recent study provided the first demonstration of a correlation between AS and 
lifespan (Skandalis et al., 2010). This correlation was the first described for any gene and 
it was found to occur in POLB. The authors observed a positive correlation between 
lifespan and the frequency of unproductive POLB SVs. The numbers of types of 
transcripts, called transcript diversity, also positively correlated with the lifespan of a 
species. This study was performed in five primate species using untransformed fibroblast 
cell lines. This is a perplexing and interesting proposal that raises many questions. We 
must ask, for example, why would an increase in defective POLB, which is used to 
maintain genomic stability, lead to long lifespan? Additionally, what function do these 
unproductive transcripts actually have?  
 A recent review suggests that available evidence shows that reduced BER 
capacity from decreased levels of POLB plays a role in accelerated rate of aging in Down 
Syndrome (Patterson et al., 2011). Although this evidence may seem contrary to 
Skandalis et al. (2010) findings we must first understand the difference between aging 
and lifespan. Aging is defined as the change in an organism over time and includes 
changes associated with loss and with gain of function, such as growth and development 
(Bowen et al., 2004). On the other hand, lifespan is a bit more difficult to define 
(Gavrilov et al., 1992). The term lifespan can refer to maximal lifespan (the maximal 
recorded life span of an individual from birth to death, based on empirical evidence), life 
expectancy (an average number of years an organism is expected to survive), or the 
longevity of an organism (the average number of years an organism is expected to 
survive under ideal conditions) (Olshansky et al., 1990). Skandalis et al. (2010) uses the 
36 
 
term “lifespan” when referring to the longevity of an organism. This definition of the 
term lifespan is also applied and used in this thesis.   
 There are many genetic factors which can contribute to the lifespan of an 
organism (Cournil et al., 2001). For example, numerous longevity genetic studies in 
Caenorhabditis elegans have shown that lifespan is linked to cascades of gene activity of 
insulin-like growth factors (reviewed by Maier et al., 2003).  In mammals, it has been 
shown that tumour protein 53 (p53) can contribute to long lifespan without resulting in 
cells growing out of control (Maier et al., 2003). Although there are numerous examples 
of genetic factors which contribute to lifespan of an organism, the idea that a positive 
correlation exists between lifespan and the production of unproductive transcripts of a 
DNA repair gene is very intriguing.  
 It is very important to recognize that Skandalis et al. (2010) were the first to 
propose this positive correlation between unproductive AS of POLB and lifespan. This 
study leads the way for future investigations. Data was gathered from five primate 
species cell lines in this study. Many research questions concerning the correlation 
between lifespan and AS of POLB remain. For example, we can ask whether this positive 
correlation exists in non-mammalian vertebrates, do non-mammalian vertebrates produce 
SVs of POLB at a frequency which correlates positively to the lifespan of the organism 
and what types of POLB transcripts do non-mammalian vertebrates produce?  
 In addition, Skandalis et al. (2010) used cell lines to gather data. Different types 
of POLB SVs have already been shown to be tissue specific (as discussed above) but it is 
important to investigate whether tissues produce the same frequency of POLB SVs? Is the 
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POLB AS frequency and positive correlation with lifespan present with regards to various 
tissue types in mammals?  
 Lastly, we ask whether the frequencies and diversity of POLB AS exist simply 
due to an organism's overall rate of AS. Based on the large scale AS studies mentioned 
above, the rates of POLB AS could be high in humans as a consequence of higher overall 
rates of AS. This question can best be addressed in species like humans or other 
mammals due to the vast collection of data on AS in these species. However, the case is 
different for non-mammalian vertebrates. Are the frequencies of POLB AS in non-
mammalian vertebrates due to an overall AS rate of the organism or is POLB unique in 
this context? These three research questions form the basis of the work to be described. 
The three major aims of the work presented here will address some of these questions.  
 The first aim of this work is to investigate POLB AS in non-mammalian 
vertebrate tissues. Once the frequencies and diversity of POLB transcripts are known in 
these species, it can be determined whether a positive correlation exists with lifespan, as 
observed in primate untransformed fibroblast cell lines. The second aim is to compare the 
data from mammalian cells lines to that of mammalian tissues. The third aim is to address 
whether the diversity and frequencies of AS of POLB is unique to this gene by using the 
AS information from a second gene for comparison.  
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METHODS 
 
Tissue collection  
 
 All tissue samples were collected following Brock University Animal Care and 
Use Committee (ACUC) guidelines. Tissue samples from the rabbit, chicken, frog, and 
bearded dragon were kept in RNA Later (Sigma, #116K0426) and stored at -80 °C. 
Tissue samples from the gull were collected according to University of British Columbia 
ACUC. Gull whole organs were extracted, pulverized and stored at -80 °C. Human RNA 
was purchased from Clonetech (Liver total RNA lot #636531, Brain total RNA lot 
#1202013).  
RNA isolation from tissue samples 
 
 Tissues were thawed and placed on a sterile surface. Using a sterile scalpel a small 
section of the tissue was cut from the whole organ. The remaining tissue sample was 
immediately placed into RNA later and stored at -80 °C. All RNA isolations from non-
mammalian tissues were performed with the RNeasy Mini Kit (Qiagen, #74104) and 
mammalian tissue RNA isolation with a Norgen RNA isolation kit (#582374). The tissues 
were homogenized one of three ways: 
1. Mortar and Pestle: The tissue sample was bathed in liquid nitrogen. Tissue was 
gently grinded with a sterile mortar and pestle. After the tissue was sufficiently 
broken down, 600 μL of lysis buffer was added.   Gentle mixing with a pipette 
created a solution of ground up tissue sample and lysis buffer (hereafter referred 
to as the “lysate”). The lysate was then used in the next steps of the RNA isolation 
protocol.  
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2. Electric Homogenizer: A small piece of tissue was put into a 2 mL flat bottom 
cryogenic vial and 600 μL of lysis buffer was added; the mixture was then 
homogenized.  
3. Manual Glass Homogenizer: A sterile manual glass homogenizer (KimbleChase, 
#885303-0002) was placed in an oven for 48 hours at 80 °C prior to use. A small 
piece of tissue was placed in the tissue grind pestle and 600 μL of lysis buffer was 
added. The tissue was homogenized and the lysate was then used in the next steps 
of the RNA isolation protocol.  
After homogenization the remaining steps for RNA isolation were followed according to 
the RNeasy Mini Handbook or Norgen handbook. Both RNA isolation kits are 
appropriate for fresh, frozen, or RNA Later stabilized animal tissues.  
Reverse transcriptase (RT) Polymerase chain reaction (PCR) – First strand cDNA 
synthesis  
 
 cDNA synthesis was carried out using Invitrogen’s first strand cDNA Superscript 
III Synthesis Kit (Invitrogen, #1015963). The procedure was carried out on ice as follows 
in a final volume of 20 μL. The following was added to a chilled 0.2 mL microcentrifuge 
tube for 1 reaction: Oligo dT(20) to a final concentration of 2.5 μM, 5 μL of RNA (1-3 ng), 
deoxynucleotide triphosphates (dNTPs) (0.5 mM), and sterile water up to 13 μL. The 
mixture heated for 5 minutes at 65 degrees C and immediately placed on ice for 1 min. 
While remaining on ice the following was added to the mixture: 5x First-Strand Buffer 
(1X), Dithiothreitol (DTT) (0.1 M), RNA inhibitor (2 units), and Superscript III (10 
units). The mixture was incubated for 50 minutes at 50 °C and finally at 70 °C for 15 
minutes. The cDNA was stored at -80 °C. 
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Primers used for initial cDNA PCR and cDNA library  
 
 Forward and reverse primers were designed specifically for some of the non-
mammalian species used based on the canonical sequences available from the NCBI 
database. For the non-mammalian species from which the canonical sequences were not 
known, degenerate primers were designed based on multiple sequence alignment of the 
most closely related species available. All POLB primers were designed to start at exon 1 
and end at exon 14. All TRPV1 primers were designed at the mRNA exon 3 (exon 
containing start codon) and end at exon 15. 
 Table 1.1 Primers designed for canonical POLB sequences in vertebrate species. 
Primer 
name 
Species  Primer sequence 
(5’  3’) 
Sequence 
length (bps) 
FxR 
Ta 
bird-polb-
for 
Chicken, Gull ATGAGCAAGCGAAAGGCNCCNCAGGAGA 
1008 
 
64.8 
bird-polb-
rev 
Chicken, Gull CCACTGTATGTANTCAAAGATGTCTTTNTCA 64.8 
Emma-polbf Chicken, Gull, 
Bearded Dragon, 
Frog 
CAGGAGAGCCTCAACNAGGGNATC 
972 
68.4 
Emma-polbr Chicken ,Gull, 
Bearded Dragon, 
Frog 
CTTTGGCTCCCGGTATTTCCACTG 68.4 
EmmaDEG
POLBf 
Chicken, Gull, 
Bearded Dragon, 
Frog 
ATGAGCAARMGNAARGCNCCNCARGAGA 
1006 
69.0 
EmmaDEG
POLBr 
Chicken, Gull, 
Bearded Dragon, 
Frog 
ATTCRCTNCGRTCYTTNGGCTCNCGGTA 69.0 
Frog-polb-f Frog AAGGAAAGCACCACAGGAGAGCCC 
997 
68.4 
Frog-polb-r Frog TCATTCGCTGCGARCCTTTGGCTC 68.4 
NewtFishP
OLBF 
Newt, Zebra Fish GCRCCACARGARWSCCYSAAYGAAGG 
993 
68.0 
NewtFishP
OLBR 
Newt, Zebra Fish TCAYTCGCTGCGRAGYAAYCCGTC 68.0 
POLBuniF1 
POLBuniR2 
POLBfor1 
POLBrev1 
Rabbit 
Rabbit 
Human 
Human 
CCGCAGGAGACCCTCAACGG 
CCACTGGATGTAATCAAAAATGTC 
TGAACACTCTCTGGGGTTCTCG 
CCAAAGACCCTTACATAGCA 
965 
 
1121 
63.0 
63.0 
64.8 
64.8 
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Table 1.2 Primers designed for canonical TRPV1 sequences in vertebrate species. 
 
Primer name Species 
designed 
for 
Primer sequence 
(5’  3’) 
Sequence 
length (bps) 
FxR 
Ta 
Emma-trpv1f Chicken, 
Gull 
CAAGGACATGGCTCCAATGGACTC 
2077 
69.0 
Emma-trpv1r Chicken, 
Gull 
CCACGTGGACCAGTTCACTTCATC 69.0 
FrogTRPV1bF Frog AAGGCCGTCGCTTTGGGAAGA 
2061 
68.5 
FrogTRPV1bR Frog AATCCTCCTTGCCGTCGGGTG 68.5 
hTRPV1F Human ACTCCTGCCCGACCATCACAGTCA 2048 68.5 
hTRPV1R Human GACGAGGTGAACTGGACCACCTGG  68.5 
Polymerase Chain Reaction (PCR) 
 
 PCRs were preformed in final volumes of 20 μL. PCR reactions were performed 
using two types of Taq Polymerases. Initial PCR from cDNA for POLB and TRPV1 for 
the frog brain and gull liver were preformed with GoTaq, TRPV1 from frog liver was 
preformed with Taq DNA Polymerase with standard 10 X Taq Buffer and all other PCR 
reactions were preformed with Taq DNA Polymerase with 10X ThermoPol Buffer. All 
PCR reactions were preformed in a final volume of 20 μL, using Taq Polymerases with 
their respective buffers, 10 mM Nucleotide solution mix (New England Biolabs), 10 μM 
forward primer, 10 μM reverse primer, and  2 μL of template.  
PCR programs  
 
 PCR programs were optimized for each primer pair. The general parameters for 
all POLB primer pairs were 94 °C for two minutes to denature DNA. Next, the reactions 
underwent 34 cycles of heating to 94 °C for 30 seconds, 56.5-70 °C for 30 seconds then 
72-74.8 °C for one minute. A final elongation of 10 minutes at 72 °C was added and the 
cycling was complete.  
PCR programs for all TRPV1 primers were as follows: 95 °C for two minutes for 
initial denaturation step followed by 30-35 cycles of heating to 95 °C, 67-70 °C for 25 
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seconds then 72-74 °C for two minutes. A final elongation time of 5 minutes at 72 °C was 
completed to finish the cycling and reactions were held at 4°C.  
Agarose gel electrophoresis 
 
 To visualize PCR products, a 0.7% agarose gel was made with 1X Tris-Acetic 
acid-Ethylenediaminetetraaceticacid (EDTA) buffer (TAE buffer). Before casting, 20 
mg/mL of ethidium bromide was added. 6X loading dye was mixed with the PCR 
product and loaded into the agarose gel. A DNA ladder was used for a marked of 
amplicon size.  The gel was then visualized under ultraviolet (UV) light and a digital 
photograph was taken.  
Ligation of PCR products 
 
 Ligation vector systems used throughout this work were TOPO TA Cloning Kit 
(Invitrogen, #45-0641) and pGEM-T Easy Vector system (Promega, #326618).  Both 
ligation systems were used for ligation of POLB PCR products for the chicken liver. 
Although both systems produced the same types of transcripts pGEM-T Easy vector 
system showed a higher efficiency and therefore was used for the remainder of the work.  
Ligations made with the TOPO TA Cloning Kit were set up with a final volume 
of 6 μL. The TOPO Cloning reactions proceeded with 1 μL of dilute salt solution, 1 μL 
pCR2.1-TOPO, PCR product 2 μL, and 2 μL of water. Reactions were gently mixed and 
incubated for 5 minutes at room temperature (22-23 °C). Reactions were stored at -20 °C 
overnight.  
pGEM-T Easy vector system ligation protocol was performed according to 
manufactures specifications. The standard ligation reactions for PCR product required 5 
μL 2X Rapid Ligation Buffer, T4 DNA Ligase, pGEM-T Easy Vector, 01-3 μL of PCR 
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product, T4 DNA Ligase (3 Weiss units), and nuclease-free water was added to a final 
volume of 10 μL. All ligations were incubated overnight at 4 °C and stored at -20 °C.  
Transformation of ligated PCR products into E.coli 
 
 Ligated PCR products were transformed with competent E.coli cells. Two 
different transformation procedures were used throughout this work, electroporation and 
heat shock. The transformation procedure determined which of the four types of 
competent E. coli cells was used. The electroporation transformation required 
electrocompenent E. coli cell types JM109 or Electromax DH10B whereas a heat shock 
transformation used heat shock competent E. coli cell types High Efficiency JM109 or 
DH5α. 
Heat shock transformation  
 
 Heat shock transformation of competent High Efficiency JM109s or DH5α E. coli 
and ligation product was done using the protocol developed by the De Luca Lab at Brock 
University (2007). An aliquot of 0.5-2 μL of ligation product was added to 100 μL of 
competent cells and mixture was incubated on ice for 20 minutes. Cells were heat 
shocked in a water bath at 42 °C for exactly 45 seconds and then chilled on ice for 5 
minutes. One mL of room temperature Super Optimal broth with Catabolite repression 
(SOC) Medium was added. Cells were cultured for 1 hour at 37°C, shaking at 
approximately 200 rpm. Cells were then plated on indicator plates.  
Electroporation transformation  
 
 Electrocompenent JM109 cells were thawed on ice. Fifty μL of cells and 1.25 μL 
of ligation reaction were added to a cooled electroporation cuvette. The cuvette was 
incubated on ice for 1 minute and then electroporated with a BioRad Gene Pulser II at 25 
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μF, 2.5 kV and 200 Ω. One mL of room temperature SOC Medium was added. Cells 
were cultured for 1 hour at 37°C, shaking at approximately 200 rpm. Electromax DH10B 
procedure was the same as JM109 cells except that 20 μL of Electromax DH10B cells 
were used and electroporated at 2.0 kV.  
Plating of competent cells  
 
 All ligation systems used provided the requirements for blue/white colour 
screening on indicator plates. Indicator plates were made with LB Agar, Ampicillin, 5-
bromo-4-chloro-indolyl-β-D-galactopyranoside (X-gal) and Isopropyl-β-D-thio-
galactoside (ITPG).  
Making indicator plates  
 
 LB agar was made by adding 15g/L of Agar (Anachmia, # 02116-300) to LB 
Media, mixed under heat, and sterilized by autoclaving. The LB agar solution was cooled 
in a water bath until temperature reached approximately 60 °C. Ampicillin was added to a 
concentration of 125 μg/mL of LB agar per plate. X-gal and IPTG were added until a 
concentration of 80 μg/mL and a 1:1 ratio was reached for each reagent respectively, per 
plate. The plates made in this fashion are hereafter referred to as Ampicillin, X-Gal, IPTG 
(A/X/I Plates). A/X/I plates were then either used immediately or wrapped in aluminum 
foil and stored at 4 °C until needed.  
Plating amounts and procedure 
 
 Aliquots of 50-150 μL of transformed E.coli cells were spread over A/X/I LB 
agar plate surface with a glass spreader. Inoculated A/X/I plates were placed upside-down 
at 37°C overnight. Resulting white bacterial colonies were then grid plated on A/X/I 
plates and incubated overnight at 37°C.    
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Making templates from grid plates 
 
 Templates for colony PCR were made with colonies from grid plates. A sterile 
toothpick was used to pick up a small portion of each colony. This portion was then 
mixed with 100 μL of autoclaved Milli-Q water and stored in a 0.2 mL microcentrifuge 
tube. This colony and water mix is hereafter referred to as “templates” and were used in 
all colony PCRs.  
Restriction endonuclease digests of PCR products  
 
 All positive colony template PCR products from each tissue sample in all species 
were digested using restriction endonucleases. All digestions were preformed according 
to manufacture guidelines.   
Table 1.3 Restriction digests of POLB PCR products for vertebrate species.   
Species  Restriction 
enzyme 
Buffer  Restriction site 
(5’  3’) 
Expected 
Fragment Sizes 
Based on 
Canonical 
Sequence (bps) 
Chicken  HindIII 
(New England 
BioLabs, #R01048) 
Buffer 2 (New England 
BioLabs, #B7002S)  
A|AGCTT 
261;384; 383 
Gull XmnI (PdmI) 
(Fermentas, 
#ER1531) 
Buffer Tango (New 
England BioLabs, 
#BY5) 
GAANN|NNTTC 
733;239 
Frog HindIII 
(New England 
BioLabs, #R01048) 
Buffer 2 (New England 
BioLabs, #B7002S) 
A|AGCTT 
537;466 
Bearded 
Dragon  
HindIII 
(New England 
BioLabs, #R01048) 
Buffer 2 (New England 
BioLabs, #B7002S) 
A|AGCTT 
625;381 
Rabbit  EcoRI Buffer 3 G|AATTC 
 
428;537 
 
Human EcoRI Buffer 3 G|AATTC 
 
428;597 
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Table 1.4 Restriction digests of TRPV1 PCR products for non-mammalian species.   
Species  Restriction enzyme Buffer Restriction site 
(5’  3’) 
Expected 
Fragment Sizes 
Based on 
Canonical 
Sequence (bps) 
Chicken  Double digest 
XmnI/EcoRI 
(Fermentas, 
#ER1531)/ 
(New England 
BioLabs,#1015) 
Double digest 
EcoRI/NcoI 
(New England 
BioLabs,#1015)/ 
(New England 
BioLabs, #R01935) 
 
Buffer Tango (New 
England BioLabs, 
#BY5)/Buffer 2 (New 
England BioLabs, 
#B7002S) 
 
 
Buffer 2 (New England 
BioLabs, 
#B7002S)/Buffer 3 
(New England Biolabs, 
#B7003S) 
 
GAANN|NNTTC/ 
G|AATTC 
 
 
 
G|AATTC/ 
C|CATGG 
 
260; 980;838 
 
 
 
 
260;406;777;634 
Frog TaqαI 
(New England 
BioLabs, #R01498) 
Buffer 3 (New England 
BioLabs, #B7003S) 
T|CGA 269;472;493;827 
     
Human NcoI    
 (New England 
BioLabs, #R01498) 
Buffer 3 (New England 
BioLabs, #B7003S) 
C|CATGG 485;653;270;640 
SV sequencing and nomenclature  
 
 Sequencing of PCR products was carried out by the McGill University and 
Genome Quebec Innovation Centre. Sequenced transcripts were compared to the CT to 
determine splicing events.  
 Splicing events are indicated with the following nomenclature: Skipped exon(s) 
are indicated by the Δ symbol followed by the name of the skipped exon(s), intron 
retentions are indicated with the Σ symbol followed by the name of the intron retained, 
and any partial exon skipping or intron retention are indicated by a "P" meaning "partial", 
a Δ or Σ symbol, and the number of the partial exon or an "I" to indicated "intron" 
followed by the partially retained intron number.  
Statistics 
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 Statistics were performed using Statistical Analysis Software (SAS).  Chi-squared 
tests were run using the number of splice variants and the number of canonical transcripts 
to determine whether a significantly statistical difference existed between the AS 
frequencies of genes within or between tissues. The significance level used for all chi-
squared tests were 0.95 (α=0.05)  
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CHAPTER TWO: Alternative splicing of POLB in non-mammals 
 
Goal of Chapter Two 
 
 The goal of this chapter is to investigate the alternative splicing (AS) of DNA 
polymerase beta (POLB) and its correlation to lifespan in four non-mammalian vertebrate 
species. The non-mammalian species in this work include Gallus gallus domesticus 
(chicken), Larus glaucescens (the glaucous-winged gull), Xenopus laevis (African clawed 
frog), and Pogona vitticeps (bearded dragon). Hereafter, animals will be designated using 
their common names.  
 This chapter will address the following questions: What are the splicing patterns 
of POLB in the liver and brain tissues, in these four non-mammalian vertebrate species? 
Is there tissue specific POLB AS patterns? Are the observed POLB AS patterns a result of 
an overall increase in AS in a given tissue type? This last question will be investigated by 
examining the splicing patterns of a second gene, TRPV1, in liver and brain tissues and 
comparing the results to the AS patterns of POLB in these same tissues. Finally, this 
chapter addresses the question: Does a positive correlation exist between AS of POLB 
and lifespan in the studied species? 
This chapter will explore three major hypotheses. Firstly, that POLB splicing is 
not tissue specific in non-mammals. Secondly, that POLB and TRPV1 have similar AS 
patterns indicating an overall trend in AS in a tissue type. The final hypothesis in this 
chapter is that POLB SV frequency from non-mammalian tissues positively correlate with 
lifespan.  
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INTRODUCTION 
 
 POLB is conserved in all vertebrate species studied to date (Uchiyama et al., 
2009). The AS patterns of POLB in mammals are well documented in the literature with 
data collections compiled largely from human cell lines and several tissues (Skandalis et 
al., 2010; Simonelli et al., 2009; Skandalis et al., 2004; Thompson et al., 2002). In 
primate primary untransformed fibroblast cell lines a positive correlation between POLB 
splice variant (SV) frequency and lifespan was observed (Skandalis et al., 2010). Whether 
this positive correlation exists in non-mammalian vertebrates has yet to be examined. If 
this correlation is found in non-mammalian vertebrates, it may suggest that the 
production of unproductive POLB SVs is an evolutionarily conserved mechanism in 
vertebrates. The research work presented here shows the AS patterns of POLB from three 
major non-mammalian vertebrate groups: avian, amphibian and reptilian.  
 Two types of avian species were investigated: one domesticated (chicken) and one 
wild (gull). This was done to observe any influence of domestication on the AS patterns 
of POLB.  Chickens have been subject to strong human driven domestication and have 
evolved with genetic adaptations (Rubin et al., 2010).  A recent study reported that Gallus 
gallus domesticus have more than 7,000,000 single nucleotide polymorphisms, almost 
1,300 deletions, and some differences in the thyroid stimulating hormone receptor 
(TSHR) compared to a major wild ancestor (Rubin et al., 2010). It is possible that 
domestication has influenced AS in the chicken. Should this be the case, then AS data 
from the chicken may not be a reliable indicator of AS patterns in the avian group.  
 To investigate AS of POLB in amphibians, liver and brain tissue was obtained 
from Xenopus laevis (frog). Tissues from an amphibian second species, Notopthalmus 
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viridescens (newt), were also tested but cloning of POLB transcripts was unsuccessful. 
Finally, tissues from the bearded dragon were obtained to investigate AS of POLB in 
reptilians. The lifespan expectancy of each of these species ranges from 12-30 years 
(Table 2.1). 
Table 2.1 Non-mammalian species lifespan data.  
Species Lifespan (years) Reference 
Chicken 30 AnAge database 
Gull 32 AnAge database 
Frog 15 Nuno et al., 2010 
Bearded Dragon 12 Reusch et al., 2009
 
 
 
 To determine whether the POLB AS patterns observed are the result of a tissue 
specific rate of AS, a second gene, described below, was introduced for comparison. The 
comparison gene had to share common features with POLB while simultaneously 
possessing stark differences. It was highly conserved across species, similar to POLB. 
This conservation had to be present not only in nucleotide sequence homology but also in 
the function of the canonical protein. The comparison gene also had a wide tissue 
distribution, like POLB. This thesis investigated tissue specific AS patterns and therefore, 
the second gene had to be expressed in all tissue types tested.  Finally, it is imperative 
that, like POLB, the comparison gene must undergo AS. The most important difference 
between the comparison gene and POLB was that it was not a DNA repair gene. This 
difference was essential because AS patterns of POLB might be common to DNA repair 
genes.  
 Based on these requirements, the gene used as a comparison for the AS of POLB 
was the transient receptor potential cation channel subfamily V member 1 (TRPV1) gene. 
TRPV1 is highly conserved across species, has a wide tissue distribution, undergoes AS 
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and is not a DNA repair gene (Cavanaugh et al., 2011, Pingle et al., 2007). Tissue 
specific AS frequencies and diversity of TRPV1 were investigated in two of the four non-
mammalian species: the chicken and the frog. Although amplification and cloning of 
TRPV1 was attempted in all non-mammals, time constraints permitted that only TRPV1 
transcripts from the chicken and frog were examined.  
TRPV1  
 
 The TRP superfamily of proteins is a group of cation channels (Moiseenkova-Bell 
et al., 2008). The TRPV1 protein was the first family member to be identified from the 
superfamily of vanilloid type of TRP nonselective cation channels (Caterina et al., 1997).  
TRPV1 is also called the capsaicin receptor because of its well studied sensitivity and 
activation to capsaicin, the natural product of the hot capsaicin peppers. TRPV1 is 
sensitive to heat (>43°C), protons (pH<6.3), vanilloids, acids, and endogenous 
proinflammatory substances (Caterina et al., 1997; Caterina et al., 2000).  Similar to the 
other members of the TRP superfamily, TRPV1 is cation nonselective having nearly 
equal selectively for Na
+
, K
+
, Li
+
, Cs
+
, and Rb
+ 
ions (Caterina et al., 1997).  
 In humans, TRPV1 is an 838- amino acid, 95-kDa protein. Similar to the other 
members of the TRP family, TRPV1 has six transmembrane (TM) domains. Between the 
fifth and the sixth TM domain is a pore-forming region which forms the ion pore to allow 
selectively of ions (Tominaga et al., 2000). The first 400 amino acids encode for the 
carboxyl terminus of the protein which contains three ankyrin-repeat domains which 
mediate protein-protein interactions (Michaely et al., 2002).  Amino acids 434-680 
encode for the six TM domains: two of which are extra cellular domains, two are 
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cytoplasmatic domains and one is a pore forming domain. Functional TRPV1 proteins 
form as tetramers existing as homo- or heteromultimers.    
 The TRPV1 gene is highly conserved across species with diverse tissue 
distribution (Cavanaugh et al., 2011, Pingle et al., 2007). The highest expression levels 
have been reported in neuronal tissues including the dorsal root ganglia and trigenminal 
ganglia in mammals (Pingle et al., 2007). Additional TRPV1 expression has been 
detected in nonneuronal tissues such as the bladder, liver and macrophages (Tominaga et 
al., 2005).  
 The mRNA sequence for the canonical TRPV1 gene, which codes for the 
TRPV1 protein, has been described in humans (Caterina et al., 1997), rat (Suzuki et al., 
1999), mouse (Caterina et al., 1999), chicken (Jordt et al., 2002), frog (Bohlen et al., 
2010), and several other species (NCBI). The human TRPV1 mRNA is 4074 base pairs. 
In all species described there are 17 exons in the mRNA transcript and 15 in the coding 
sequence (CDS). TRPV1 undergoes AS to form several SV forms (Gracheva et al., 2011; 
Tian et al., 2006; Wang et al., 2004; Schumacher et al., 2000).  
 To date there have been five SVs of the TRPV1 mRNA identified. The first SV, 
VR.5'sv, was observed in rat tissues (Schumacher et al., 2000). This SV lacks exons 1-5 
and 7. Starting translation at exon 6, the protein produced lacks the N cytoplasmic 
domain and the first two ankyrin repeats. It is not activated by capsaicin, protons or 
temperature and does not produce and a functional channel (Schumacher et al., 2000). It 
has been proposed that VR.5'sv protein functions as a negative modulator to canonical 
TRPV1 activation (Eilers et al., 2007).  
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 Wang et al. (2004) described the second TRPV1 SV, TRPV1β in dorsal root 
ganglia tissue of mice. This variant is missing the last 30 bps in exon seven resulting in a 
deletion of 10 amino acids between the third ankyrin repeat and the first TM domain. 
When expressed alone TRPV1β is not functional. When this variant is co-expressed with 
canonical TRPV1, TRPV1β inhibits expression of TRPV1 in mice, thereby acting as a 
dominant negative regulator (Wang et al., 2004).  
 Lu et al. (2005) described a TRPV1 variant with an exon seven deletion. This 
variant was found to be expressed in human tissues and is called hTRPV1b (Lu et al., 
2005). Interestingly, this variant produces a functional protein despite missing 60 amino 
acids from the cytoplasmic domain, the first two ankyrin repeats and part of the third one. 
hTRPV1b has been shown to be activated by temperature but not capsaicin or protons 
(Lu et al., 2005).  
 TRPV1(VAR) is the name of the fourth known TRPV1 SV described by Tian et 
al. (2006). It is the first of two described TRPV1 variants with an intron retention AS 
event. This variant retains 101 bps between exons five and six that contains a PTC at 
amino acid position 254. The PTC results in a truncated protein of 253 amino acids. This 
variant has been shown to act as a dominant negative regulator or potentiator of canonical 
TRPV1 expression, depending on cell type used (Tian et al., 2006).  
 Finally Gracheva et al. (2011) revealed the newest addition of TRPV1 SVs, 
TRPV1-S, was recently found in vampire bats. TRPV1-S is the second TRPV1 variant 
described with an intron retention AS event. This 23 bp inclusion after exon 14 contains a 
stop codon which leads to the production of a short (-S) transcript. Production of the 
TRPV1-S protein results in a channel that has a lower thermal activation threshold (~30 ° 
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C). It has been proposed that this channel allows vampire bats to physiologically tune 
their thermosensory nerve fibers (Gracheva et al., 2011).  
 Transcripts of POLB and TRPV1 were collected and characterized from liver 
and brain tissues from all four non-mammalian species. In all cases, except the brain 
tissue from the bearded dragon, POLB showed SV frequencies of <3.2%. AS of POLB 
was shown to be tissue specific in the gull and the bearded dragon. No statistical 
difference existed in the AS of POLB in the brain tissues between the chicken and the 
gull, whereas a statistically significant difference was observed in liver tissues. TRPV1 
and POLB splicing demonstrated statistically significant differences in both the chicken 
and the frog tissues.  
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RESULTS 
AS of POLB in chicken tissues 
 
 POLB cloned transcripts were successfully amplified from chicken liver and brain 
tissues (Figure 2.1, lanes 4 and 6). The resulting size of the PCR product was 
approximately 1008 bps. (Table 1.1). A total of 155 and 74 POLB transcripts were 
characterized from the chicken liver and brain tissues, respectively.  
 
 
  
 
Figure 2.1 POLB PCR products amplified from chicken liver and brain tissue cDNA.  
 Lane 1 shows the DNA size marker. Lane 2 contains a negative control, in which no 
cDNA was added to the reaction mixture, but water was. Lane 3 contains a positive 
control, in which mammalian cDNA was used with mammalian POLB primers. Lanes 4 
and 6 show POLB PCR product from the chicken liver and brain tissues, respectively.  
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AS of POLB in chicken liver tissue 
 
 Of the 155 POLB transcripts characterized from chicken liver tissue five were 
SVs. The POLB SV frequency in chicken liver was found to be 3.2% (Table 2.4). The 
POLB transcript diversity was 3 (Table 2.3). A POLB transcript with intron one retention 
was characterized, ΣI1 (Table 2.2, Figure 2.4). The inclusion of intron one disrupts the 
reading frame and creates a PTC in exon two. Of the 155 POLB transcripts from the 
chicken liver this SV was detected three times (frequency of 1.9%) (Figure 2.2). The only 
other POLB SV characterized in the chicken liver tissue was a partial 48 bp skip of exon 
13, Δp1348 (Figure 2.3). This partial exon skip does not disrupt the reading frame. Two of 
these SVs were found out of the 155 total characterized (frequency of 1.3%) (Figure 2.2).  
AS of POLB in chicken brain tissue 
 
 Of the 74 POLB transcripts from chicken brain two were SVs of one type, ΣI1 
(Figure 2.3). The SV frequency and transcript diversity in the brain tissue were 2.8% and 
two, respectively (Table 2.3). No statistically significant difference was observed in 
POLB SV frequency between the two tissue types (x
2=0.03, d.f=1, p=0.85, α=0.05) 
(Table 2.3).  
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Figure 2.2 POLB CT and SV frequencies of the chicken liver and brain tissues.  
 
 
  
Figure 2.3 POLB transcript types characterized from the chicken liver and brain tissues. 
* Indicates location of a PTC.  
 
 
 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
WT ΣI1 ∆p13₄₈ 
P
O
L
B
 t
ra
n
sc
ri
p
t 
fr
eq
u
en
cy
 (
%
) 
POLB transcript type 
Chicken liver tissue 
Chicken brain tissue 
CT 
58 
 
 
Table 2.2 POLB ΣI1 from the liver and brain tissues in the chicken.  
Name Sequence  
Intron 1 GGTATGGGGGGGCGCGGGGAGGGGGCGTCCTGGGATTCGGCTCGG
CTGTTCCAACTGTGTTTCTCCCCGTA 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3 POLB frequency of AS and transcript diversity in chicken liver and brain 
tissues.  
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity 
in tissue 
type 
Liver  Canonical transcript  150 
3.2 3 
 Splice variant  5 
Brain Canonical transcript 70 
2.8 2 
 Splice variant 2 
       Splice variant frequency: the relative frequency of splice variants compared to the total 
       number of transcripts characterized 
       Transcript diversity: The number of different types of transcripts observed (including CT) 
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AS of TRPV1 in chicken tissues 
 
 TRPV1 cloned transcripts were successfully amplified from the chicken liver and 
brain (Figure 2.4, lanes 6 and 8). The resulting size of the PCR product was 
approximately 2077 bps (Table 1.2). A total of 91 and 103 TRPV1 transcripts were 
characterized from the chicken liver and brain tissues, respectively.  
 
 
 
 
 
Figure 2.4 TRPV1 PCR products amplified from chicken liver and brain tissue cDNA. 
Lane 1 shows the DNA size marker. Lane 2 contains a negative control, in which no 
cDNA was added to the reaction mixture, but water was. Lanes 3-5 show lack of 
amplification of TRPV1 from cDNA from the bearded dragon. Lane 6 shows successful 
amplification of TRPV1 from cDNA from the chicken brain. Lane 7 shows lack of 
amplification of TRPV1 from cDNA from the chicken muscle. Lane 8 shows successful 
amplification of TRPV1 from cDNA from the chicken liver.   
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AS of TRPV1 in chicken liver tissue 
 
 Of the 91 TRPV1 transcripts characterized in the chicken liver tissue 71 were SVs. 
The SV frequency and transcript diversity of TRPV1 was 78% and seven, respectively 
(Table 2.4). The most common SV observed in this tissue type was ∆12 (Figure 2.6). 
This transcript accounted for 56 of the total 91 transcripts (frequency of 62%) and is 1911 
bps in length (Figure 2.5). Exon 12 of TRPV1 is 166 bps and the skip of this exon 
resulted in a PTC. The second most common TRPV1 SV in the chicken liver was ∆p463 
(Figure 2.6). The ∆p463 SV would result in a 2015 bps transcript. This SV occurred at a 
frequency of 5.5% (5/91) (Figure 2.5). The skip of the partial exon four did not result in a 
PTC. Another skip of a partial exon was observed in the TRPV1 SV, ∆p850 (Figure 2.6). 
This splicing event would result in a total TRPV1 transcript size of 2027 bps. This SV 
occurred at a frequency of 3.3% (3/91) (Figure 2.5). The skip of the partial exon eight 
resulted in a PTC in the ∆p850 TRPV1 transcript.  
 A second complete exon skip event was observed in the TRPV1 SV ∆6 (Figure 
2.6). This SV occurred at a frequency of 1% (1/91) (Figure 2.5). Exon six of the 
canonical chicken TRPV1 transcript is 141 bps in length and the skip of this exon did not 
result in a PTC. Another type of TRPV1 splicing event observed was multiple exon 
skipping, specifically exons five and six (Figure 2.6). This ∆5,6 TRPV1 SV occurred at a 
frequency of 2.2% (2/91) (Figure 2.5). No PTC was created from the multiple skip of 
exons five and six.  
 Finally, one intron retention splicing event of intron 15 (∑I15) was observed in 
one of the 91 transcripts (frequency of 1.0%) (Figure 2.5 and 2.6). This intron retention 
would result in a total transcript length of 2607 bps and the creation of a PTC. 
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AS of TRPV1 in chicken brain tissue 
  
 Of the 103 TRPV1 transcripts characterized in the chicken liver six were SVs. The 
SV frequency and transcript diversity of TRPV1 in the chicken liver was 5.8% and four, 
respectively (Table 2.4). The types of SVs observed were ∆p463, ∆6 and ∆12, all of which 
occurred at a frequency of 1.9% each (2/103) (Figure 2.5 and 2.6). A statistically 
significant difference was found between chicken liver and brain tissues in TRPV1 SV 
frequencies (Table 2.4) (x
2
=107.7, d.f=1, p=<0.0001, α=0.05) 
 
 
 
Figure 2.5 TRPV1 CT and SV frequencies of the liver and brain tissues in the chicken.  
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Figure 2.6 TRPV1 transcript types characterized from the chicken liver and brain tissues. 
* Indicates location of a PTC.  
 
 
 
 
 
 
Table 2.4 TRPV1 frequency of AS and transcript diversity in chicken liver and brain 
tissues. 
Tissue 
type 
Type of transcript Number of 
transcripts found 
Splice variant 
frequency 
(%) 
Diversity (#) 
in tissue type 
Liver  Canonical transcript 20 
78.0 7 
 Splice variant  71 
Brain Canonical transcript 100 
5.6 4 
 Splice variant  6 
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POLB and TRPV1 SV frequencies in the liver and brain tissues of the chicken  
 
 There was no statistically significant difference found between POLB SV 
frequency in chicken liver compared to brain (x
2
=0.03, d.f=1, p=0.85, α=0.05) (Figure 
2.7). TRPV1 does show statistically significant difference between tissues types in both 
SV frequency and transcript diversity (x
2=107.7, d.f=1, p=<0.0001.,α=0.05) (Figure 2.7). 
Statistically significant differences were found between POLB and TRPV1 SV 
frequencies in the liver and the brain tissue, respectively (x
2
=0.8300, d.f=1, p=0.3623, 
α=0.05) (x2=150.2, d.f=1, p=<0.0001, α=0.05) (Figure 2.7) 
 
Figure 2.7 SV frequencies of POLB and TRPV1 in the chicken liver and brain tissues.  
 
 
 
 
 
 
 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
Chicken Liver 
POLB 
Chicken Brain 
POLB 
Chicken Liver 
TRPV1 
Chicken Brain 
TRPV1 
S
p
li
ce
 v
ar
ia
n
t 
fr
eq
u
en
cy
 (
%
) 
Species and tissue type 
64 
 
AS of POLB in gull liver tissues 
 
 POLB cloned transcripts were successfully amplified from gull liver and brain 
tissues (Figure 2.8, lane 2 and 2.9, lane 8). The resulting size of the PCR product was 
approximately 972 bps (Table 1.1). A total of 98 and 73 POLB transcripts were 
characterized from the gull liver and brain tissues, respectively. 
 
     
Figure 2.8 POLB PCR products amplified from gull liver tissue cDNA. Lane 1 shows the 
DNA size marker. Lane 2 shows successful amplification of POLB using emmaPOLBf x 
emmaPOLBr. Lane 3 shows successful amplification of POLB using emmaPOLBf 
xPOLBDEGR. Lane 4 shows successful amplification of POLB using POLBDEGF x 
emmaPOLBr. Lane 5 shows successful amplification of POLB using POLBDEGF x 
POLBDEGR. The POLB transcript PCR product from lane 2 was used for all other gull 
liver POLB experiments.  
 
    
Figure 2.9 POLB PCR products amplified from gull brain tissue cDNA. Lane 1 shows 
the DNA size marker. Lane 2 contains a negative control, in which no cDNA was added 
to the reaction mixture, but water was. Lane 3 contains a positive control, in which gull 
liver colony template was used. Lane 4 shows successful amplification of POLB from 
cDNA from the chicken brain. Lanes 5, 6 and 7 shows lack of amplification of POLB 
from cDNA from the gull liver, scaap brain and mall liver, respectively. Lane 8 shows 
successful amplification of POLB from cDNA from the gull brain.  
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AS of POLB in gull liver tissue 
 
 Of the 98 POLB transcripts characterized from the gull liver tissue one was 
determined to be a SV. This POLB SV was a partial intron inclusion of 83 bps of intron 
seven (ΣpI783) and occurred at a frequency of 1.0% (1/98) (Figure 2.10 and 2.11). This 
splicing event resulted in a PTC in exon four of the POLB transcript. A partial 972 bps of 
the canonical gull POLB transcript was cloned and characterized from this data (NCBI#: 
JN620209.1). 
AS of POLB in gull brain tissue 
 
 Of the 72 POLB transcripts characterized from the gull brain two were SVs of two 
types. The POLB SV frequency in the gull brain was 2.8% with a transcript diversity of 
three (Table 2.5). The first type of SV characterized was a complex splicing event 
involving exons two and three skipping with an inclusion of 83 bps of intron 7 
(ΣpI783∆2,3) (Figure 2.11). This SV was observed in one out of 72 transcripts (frequency 
of 1.4%) (Figure 2.10). The skip of POLB exons two and three resulted in a PTC in exon 
four. The second POLB SV observed had a frequency of 1.4% (1/72) and was 
characterized by an inclusion of 83 bps of intron seven (Figures 2.10 and 2.11). The 
ΣpI783 SV contains a PTC as a result of the partial intron retention. There a statistically 
significant difference in POLB SV frequency between gull liver and brain tissues (x
2
:  
0.7394, d.f=1, p=0.3898, α=0.05) (Table 2.5).  
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Figure 2.10 POLB CT and SV frequencies of the liver and brain tissues in the gull. 
 
 
 
 
 
Figure 2.11 POLB transcript types characterized from the gull liver and brain tissues.  
* Indicates location of a PTC.  
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Table 2.5 POLB frequency of AS and transcript diversity in gull liver and brain tissues. 
 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity in 
tissue type 
Liver  Canonical transcript 97 
1 2 
 Splice variant 1 
Brain Canonical transcript 70 
2.8 3 
 Splice variant 2 
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AS of POLB between avian species liver and brain tissues 
 
 No statistically significant difference in POLB SV frequency was observed 
between brain tissues of avian species (x
2: 0, d.f=1, p=1.0, α=0.05) (Figure 2.12). In the 
liver tissues of the avian species a statistically significant difference was observed (x
2
:  
1.2613, d.f=1, p=0.2614, α=0.05) (Figure 2.12).  
 
 
 
Figure 2.12 POLB SV frequencies of the liver and brain tissues of avian species. In all 
tissue types the POLB SV frequency was >3.2% in avian species.  
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AS of POLB in frog tissues 
 
 POLB cloned transcripts were successfully amplified from frog liver and brain 
(Figure 2.13 lane 3 and 2.14 lane 5). The resulting size of the PCR product was 
approximately 1003 bps (Table 1.1). A total of 110 and 127 POLB transcripts were 
characterized from the frog liver and brain, respectively.  
    
Figure 2.13 POLB PCR products amplified from frog liver tissue cDNA Lane 1 shows 
the DNA size marker. Lane 2 contains a negative control, in which no cDNA was added 
to the reaction mixture, but water was. Lane 3 shows successful amplification of POLB 
from cDNA from the frog liver. 
 
 
 
Figure 2.14 POLB PCR products amplified from frog brain tissue cDNA. Lane 1 shows 
the DNA size marker. Lane 2 contains a negative control, in which no cDNA was added 
to the reaction mixture, but water was. Lanes 3 and 4 show successful amplification of 
POLB from bearded dragon liver cDNA. Lanes 5 and 6 show successful amplification of 
POLB from the frog brain cDNA.  
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AS of POLB in frog liver tissue 
 
 Of the 110 POLB transcripts characterized the frog liver one SV was observed. 
The POLB SV frequency in the frog liver was 0.9% with a transcript diversity of two 
(Table 2.6). The single type of POLB SV observed was retention of 681 bp of intron two 
(∑pI2681) (Figure 2.16). This SV occurred at a frequency of 0.9% (1/110) (Figure 2.15). 
The retention of this partial intronic sequence created a PTC in the transcript.  
AS of POLB in frog brain tissue 
 
 Of the 127 POLB transcripts characterized the frog brain two SVs were observed. 
The POLB SV frequency in the frog brain was 1.6% with a transcript diversity of three 
(Table 2.6). ∑pI2616 was one of the SV types observed, occurring at a frequency of 0.8% 
(1/127) (Figure 2.15 and 2.16). The second type was a multiple exon skip splicing event 
of exons two and three (∆2,3) (Figure 2.16) . The ∆2,3 POLB SV occurred at a frequency 
of 0.8% (1/127) (Figure 2.15). Exons two and three skipping resulted in a 125 bp shorter 
transcript compared to the canonical transcript and the creation of a PTC. No statistically 
significant difference was found in POLB SV frequencies between frog liver and brain 
tissues (x
2=0.21, d.f=1, p=0.65, α=0.05). 
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Figure 2.15 POLB CT and SV frequencies of the liver and brain tissues in the frog. 
 
 
 
 
 
 
Figure 2.16 POLB transcript types characterized from the liver and brain tissues of the 
frog. * Indicates location of a PTC.  
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Table 2.6 POLB frequency of AS and transcript diversity in frog liver and brain tissues. 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity in 
tissue type 
Liver  Canonical transcript 109 
0.9 2 
 Splice variant 1 
Brain Canonical transcript 125 
1.6 3 
 Splice variant 2 
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AS of TRPV1 in frog tissues 
 
 TRPV1 cloned transcripts were successfully amplified from frog liver and brain 
(Figure. 2.17, lane 3 and 2.18, lane 5). The resulting size of the PCR product was 
approximately 2061 bps (Table 1.2). A total of 112 and 95 TRPV1 transcripts were 
characterized from the frog liver and brain, respectively.  
 
Figure 2.17 TRPV1 PCR products amplified from frog liver tissue. Lane 1 shows the 
DNA size marker. Lanes 2 and 3 are duplicate PCR reactions which show successful 
amplification of TRPV1 from the frog liver cDNA. 
 
Figure 2.18 TRPV1 PCR products amplified from frog brain tissue. Lane 1 shows the 
DNA size marker. Lane 2 shows lack of amplification of TRPV1 using TRPV1for x 
TRPV1rev. Lane 3 shows successful amplification of TRPV1 using TRPV1for x 
TRPV1bREV. Lane 4 shows successful amplification of TRPV1 using TRPV1bFOR x 
TRPV1rev. Lane 5 shows successful amplification of TRPV1 using TRPV1bFOR x 
TRPV1REV.  
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AS of TRPV1 in frog liver tissue 
 
 Of the 112 TRPV1 transcripts characterized from the frog liver none were SVs. 
The TRPV1 SV frequency and transcript diversity of TRPV1 in the frog liver was 0% and 
one, respectively.  
AS of TRPV1 in frog brain tissue 
 
 Of the 95 TRPV1 transcripts characterized from the frog brain four were SVs. The 
TPRV1 SV frequency and transcript diversity in the frog brain was 4.1% and two, 
respectively (Table 2.7). The single type of SV observed was an exon skip event resulted 
in exon 13 skip (Δ13) (Figure 2.20). This TRPV1 SV occurred at a frequency of 4.2% 
(4/95) (Figure 2.19). Exon 13 skip in the TRPV1 transcript resulted in a PTC in exon 14. 
There is a statistically significant difference in TRPV1 SV frequencies between frog liver 
and brain tissues (x
2
:  4.3719, d.f=1, p=0.0365, α=0.05). 
 
 
 
Figure 2.19 TRPV1 CT and SV frequencies of the liver and brain tissues in the frog. 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
WT Δ13 
T
R
P
V
1
 t
ra
n
sc
ri
p
t 
fr
eq
u
en
cy
 (
%
) 
TRPV1 transcript type 
Frog liver tissue 
Frog brain tissue 
C  
75 
 
 
Figure 2.20 TRPV1 transcript types characterized from the frog liver and brain tissues. 
* Indicates location of a PTC.  
 
 
 
 
 
 
 
 
 
 
Table 2.7 TRPV1 frequency of AS and transcript diversity in frog the liver and brain. 
 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity (#) 
in tissue type 
Liver  Canonical transcript 112 
0 1 
 Splice variant  0 
Brain Canonical transcript 91 
4.1 2 
 Splice variant 4 
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TRPV1 and POLB SV frequencies in the frog liver and brain tissues   
 
 There is a statistically significant difference between POLB SV frequencies and 
TRPV1 SV frequencies in the liver of the frog (x
2
: 1.8702, d.f=1, p=0.1714, α=0.05) 
(Figure 2.21). In the frog brain there is a statistically significant difference between 
POLB SV frequencies and TRPV1 SV frequencies (x
2: 1.3393, d.f=1, p=0.2472, α=0.05) 
(Figure 2.21).  
 
 
 
 
Figure 2.21 SV frequencies of POLB and TRPV1 in frog liver and brain.  
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AS of POLB in bearded dragon tissues 
 
 POLB cloned transcripts were successfully amplified from bearded dragon liver 
and brain (Figure 2.22, lane 4 Figure 2.23 lane 4). The resulting size of the PCR product 
was approximately 1006 bps (Table 1.1). A total of 99 and 114 POLB transcripts were 
characterized from the frog liver and brain, respectively. A partial 1,006 bps of the 
canonical bearded dragon POLB transcript was cloned and characterized from this data 
(NCBI#: JN620208.1). 
         
    
Figure 2.22 POLB PCR products amplified from bearded dragon liver tissue. Lane 1 
shows the DNA size marker. Lane 2 contains a negative control, in which no cDNA was 
added to the reaction mixture, but water was. Lanes 3 and 4 show duplicate successful 
amplification of POLB from bearded dragon liver cDNA.  
                    
 
Figure 2.23 POLB PCR products amplified from bearded dragon brain tissue. Lane 1 
shows the DNA size marker. Lanes 2 and 3 show lack of amplification from bearded 
dragon liver cDNA. Lane 4 shows successful amplification of POLB from bearded 
dragon brain cDNA. 
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AS of POLB in bearded dragon liver tissue 
 
 Of the 99 POLB transcripts characterized from the bearded dragon liver, two were 
SVs. The POLB SV frequency in the bearded dragon liver was 2.0% with a transcript 
diversity of three (Table 2.8). The first type of SV was ∆2 which occurred with a 
frequency of 1.0% (1/99) (Figure 2.24 and 2.25). Skip of POLB exon 2 resulted in an in 
frame PTC in exon three. The other SV characterized as a complete intron seven retention 
(ΣI7) (Figure 2.25). This SV occurred at frequency of 1.0% (1/99) and contained a PTC 
in the retained intronic sequence (Figure 2.24).  
AS of POLB in bearded dragon brain tissue 
 
 Of the 114 POLB transcripts characterized the bearded dragon brain 11 SVs were 
observed. The POLB SV frequency in the bearded dragon brain was 9.6% with a 
transcript diversity of two (Table 2.8). This represented the highest POLB SV frequency 
in tissues from all non-mammalian species investigated. The one type of SV observed 
was ∆2 and it occurred at a frequency of 9.6% (11/114) (Figure 2.24 and 2.25). There 
was a statistically significant difference found in POLB SV frequency between bearded 
dragon liver and brain tissues (x
2
=0.5, d.f=1, p=0.019, α=0.05). 
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Figure 2.24 POLB CT and SV frequencies of the bearded dragon liver and brain tissues.  
 
 
 
 
 
 
 
 
 
Figure 2.25 POLB transcript types characterized from the liver and brain tissues of the 
bearded dragon. * Indicates location of a PTC.  
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Table 2.8 POLB frequency of AS and transcript diversity in bearded dragon liver and 
brain tissues. 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity in 
tissue type 
Liver  Canonical transcript 97 
2.0 3 
 Splice variant 2 
Brain Canonical transcript 103 
9.6 2 
 Splice variant 11 
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AS of POLB and lifespan in non-mammalian tissues 
 
  The relationship between POLB SV frequency, transcript diversity and lifespan is 
shown in Figures 2.26 and 2.27. In the liver tissues of non-mammalian species AS of 
POLB did not correlate well with log lifespan (SV frequency r
2
=0.0512, n.s; diversity 
r
2
=0.0255, n.s) (Figure 2.26). In the brain tissues of non-mammalian species AS of POLB 
AS did not correlate well with log lifespan (SV frequency r
2
=0.0255, n.s; diversity 
r
2
=0.0255, n.s) (Figure 2.27).  
 
 
 
 
 
Figure 2.26 POLB SV frequency and transcript diversity with lifespan in liver tissues of 
non-mammalian species. 
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Figure 2.27 POLB SV frequency and transcript diversity with lifespan in brain tissues of 
non-mammalian species. 
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DISCUSSION 
 
 Although AS has been studied extensively in mammals, far fewer studies have 
focused on the phenomenon in non-mammals (Eichner et al., 2011; Schindler et al., 
2007). The majority of non-mammalian studies have focused on the AS of a single gene 
within one species. In cases of large scale EST or microarray studies the AS rates of 
certain genes have been reported for a few non-mammals, such as the domestic chicken 
(Kim et al., 2007, Artamonova et al., 2007). POLB is a highly conserved gene among 
vertebrate species (Uchiyama et al., 2009). In mammals there is an 87% conservation of 
POLB at the nucleotide level between rats and humans (Skandalis et al., 2010). In non-
mammals, POLB mRNA sequence is also conserved. For example, there is 75% 
nucleotide level conservation between the domestic chicken and the African clawed frog.  
 Skandalis et al. (2010) revealed that POLB SV frequency varies, ranging from 
12% to 57%, in the primary untransformed fibroblast cell lines of several primate species. 
The POLB splicing patterns in non-mammals were unknown prior to the work in this 
thesis. This chapter presents the analysis of data collected from individuals of three non-
mammalian classes consisting of four orders: the chicken (Aves, Galliformes), glaucous-
winged gull (Aves, Charadriiforms), African clawed frog (Amphibia, Anura), and 
bearded dragon (Reptilia, Squamata). Investigation in these species revealed that in 
comparison to mammals, POLB SV frequency and transcript diversity are low (<3.2%) in 
the liver and brain tissues in the majority of these non-mammalian species.  
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POLB SV frequency  
 The lowest POLB SV frequency was observed in the frog liver at 0.9%. The frog 
brain showed similar POLB SV frequency, at 1.6%. There is no indication of tissue 
specific AS of POLB in these two frog tissues. This is the first demonstration of the AS 
of POLB in a frog species and therefore, whether these frequencies are similar to those 
present in other amphibians is unknown at this time. Venables et al. (2012) reported the 
AS of other genes, for example, RNA-binding splicing factor (RBFOX), are found to 
alternatively splice in a tissue specific manner in the muscle and heart of the frog. 
However, the SV frequency of these AS events was not reported.  
 Similar POLB SV frequencies seen in frog tissues were observed in gull liver and 
brain tissues. These tissues did show a statistically significant difference in POLB SV 
frequencies; however this could be due to the number of transcripts analysed for each 
tissue. This may not represent a significant biological difference.  To date there has been 
no investigation of the AS of any gene in the glaucous-winged gull other than the work 
presented in this chapter; however the POLB AS patterns of the gull were compared to 
those of another avian species, the chicken.   
 Two avian species were investigated in this work because of the possible 
influence of wide spread domestication of the chicken. The POLB SV frequencies were 
found to be higher in the chicken liver and brain tissues, 3.2% and 2.8%, respectively, 
compared to the gull tissues. There was no tissue specific splicing of POLB observed 
between the chicken liver tissue compared to the chicken brain tissue. A chi-square test 
between the POLB SV frequencies in the brain tissues of the two avian species showed 
no statistically significant difference. Interestingly, the liver tissues did show a 
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statistically significant difference for POLB SV frequency between the avian species. 
This result could suggest that widespread domestication of the chicken has affected the 
AS of certain genes in a tissue specific manner. While a recent study showed that other 
genes in the chicken alternatively splice in a highly tissue specific manner however the 
study did not comment on whether this could have been a result of domestication 
(Terenzi et al., 2010). Other studies have shown that the chicken has a whole organism 
AS rate of 42% with no suggestion of tissue specific AS events (Kim et al., 2007; 
Artamonova et al., 2007). These studies do not report the frequency at which the 
alternatively spliced genes occur. The results presented in this chapter show that POLB 
SV frequency in the chicken is similar to other non-mammalian vertebrates, and that 
these frequencies are low compared to primate species.  
 The highest POLB SV frequency of the four non-mammals was found in the 
bearded dragon brain, which occurred at 9.6%. This was 7.4% higher than the SV 
frequency in the bearded dragon liver. There was a statistically significant difference 
between the POLB SV frequency between the liver and the brain tissue of the bearded 
dragon. Chen et al. (1997) showed that other genes in reptiles do demonstrate tissue 
specific AS. 
 With the exception of the bearded dragon, the non-mammalian tissues were 
obtained from individuals in the young adult stage of life. Tollervey et al. (2011) reported 
a general increase in AS with age in humans. The bearded dragon liver and brain tissues 
were obtained from an individual of 11 years of age while the recorded lifespan of a 
bearded dragon is 12 years (Reusch et al., 2009). The higher POLB SV frequency in this 
species as compared to the other non-mammals could be a consequence of advanced age.  
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 Taken together, the POLB SV frequencies in these species are lower than reported 
in primates by Skandalis et al. (2010). There appears no tissue specific AS of POLB 
between liver tissues compared with brain tissues in the majority of non-mammalian 
vertebrates.  
POLB transcript diversity 
 The POLB transcript diversity was lower in all non-mammals as compared to 
primates (Skandalis et al., 2010). No more than one to two types of POLB SVs were 
observed in these species compared to the >6 - 14 types of SVs in reported for primate 
species (Skandalis et al., 2010). This result suggests that the chicken, gull, frog and 
bearded dragon produce fewer different types of POLB SVs than primates.   
 A single type of POLB AS event appears to be conserved: the skip of exon two. 
The Δ2 POLB SV was observed in some form in all non-mammals with the exception of 
the chicken. In two cases, the gull and the frog, the skip of exon two was always involved 
in a multiple exon skip which included exon three. Additionally, the skipping of exon two 
AS events in POLB SVs was only observed in brain tissue. In humans, Δ2 has been 
observed in bladder tissues, gastric tissues and blood samples from healthy individuals as 
well as various cancer cell types (Simonelli et al., 2009; Thompson et al., 2002). 
Skandalis et al. (2010) suggest that the Δ2 SV is evolutionarily conserved among primate 
species. The data in this chapter presents the first evidence of the Δ2 POLB variant in 
non-mammalian vertebrates, which suggests that this SV may be conserved in the 
majority of vertebrates. This SV does not produce a functional protein and has been 
proposed to act as a dominant negative regulator of normal POLB activity (Thompson et 
al., 2002). Recently, it has been strongly suggested that the Δ2 variant functions as a non-
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coding RNA that plays a role as a post-transcriptional regulator in humans (Simonelli et 
al., 2009). Whether exon two skip in POLB SVs has similar functions in the brain of the 
species investigated in this chapter as those suggested in humans is currently unknown.  
Intron retention AS events  
 Intron retention AS events in POLB SVs, either full or partial, were observed in 
all species investigated in this chapter. In general, vertebrates have short exons compared 
to introns (reviewed by Keren et al., 2010). The number of large introns, >50 kbs, has 
been shown to increase from non-mammals to mammals (Shepard et al., 2009).  
 The PCR conditions and Taq polymerase used in this thesis work are generally 
capable of amplifying products <2.0kb (Evans 2008; Barnes 1994).  Introns that are short 
in length may not have been spliced out of the mRNA at the time of the total RNA 
isolation and therefore may have been observed in the cloned transcripts. For example, 
intron one of POLB in the chicken is 71 bps. This small intron may have been detected 
simply because it had not yet been spliced out of the mRNA during co-transcriptional 
splicing, and not necessarily because it was an intron retention AS event. To investigate 
whether the intron retention event observed in the chicken POLB AS patterns was due to 
the small intron length, POLB transcripts could be characterized from isolated nuclear 
and cytoplasmic RNA fractions and compared. If the intron was present in a POLB 
transcript detected from cytoplasmic RNA, this would suggest an intron retention AS 
event.  
 The intron retention AS events observed in non-mammalian POLB SV may be a 
result of the secondary structures of the polypyrimidine binding tract (PPT) of the intron. 
Recently, Vargas et al. (2011) found evidence that indicated the spliceosome assembled 
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at each intron independently, in turn catalyzing the splicing reaction depending on the 
unique kinetics of each intron. Furthermore, authors observed that when an intron's PPT 
formed strong secondary structures splicing of the intron was delayed until after 
transcription was complete even though all other introns were co-transcriptionally spliced 
out (Vargas et al., 2011). This delay resulted in an accumulation of incompletely spliced 
mRNAs in the nucleus. The intron retention AS events seen in non-mammalian POLB 
transcripts could be a result of the secondary structures formed by the intron's PTT and 
this unique circumstance of uncoupled splicing. Unfortunately, since the POLB intronic 
sequences are unknown for three out of the four species in this chapter an analysis of 
possible intron secondary structures across these species was not possible.  
POLB AS patterns versus TRPV1 patterns 
 Chicken and frog POLB AS patterns were compared to the patterns of a second 
gene, TRPV1, to investigate whether the observed POLB splicing patterns occurred due to 
a systemic (overall) increase in AS in a particular tissue type. Both the chicken liver and 
the brain showed statistically significant differences in the SV frequencies of POLB and 
TRPV1. TRPV1 SV frequency in the chicken liver was increased compared to the POLB 
SV frequency, at 78.0% and 3.2%, respectively. This result suggests that the chicken liver 
is not subject to an overall increase in AS. If the liver of the chicken had increased AS 
frequencies for all genes as compared to the brain then high SV frequencies of both 
POLB and TRPV1 would be observed. This was not reflected in the data presented in this 
chapter. The brain and liver tissue of the chicken showed similar results; both tissues had 
higher SV frequency of TRPV1 compared to POLB.  
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 The frog liver and brain tissues also showed statistically significant differences in 
POLB and TRPV1 SV frequencies. In the frog brain tissue, POLB and TRPV1 SV 
frequencies were higher than in the liver. No TRPV1 SVs were detected in the frog liver 
whereas POLB SVs were observed. These data may suggest that AS of all genes is higher 
in the brain compared to the liver for this species. To further investigate this possibility, 
future studies should examine the AS patterns of various genes in these two tissues in 
non-mammals. The genes investigated in those studies should be a combination of DNA 
repair genes, non-DNA repair genes and additional genes of cation channels. If the AS 
patterns of all genes are increased in brain tissue as compared to liver tissue this would 
provide further data to suggest the presence of an overall increase in AS in particular 
tissues of this species.  
 Chickens are insensitive to capsaicin because the avian TRPV1 channel fails to be 
activated by capsaicin, although it is still sensitive to heat and protons (Jordt et al., 2002). 
Jordt et al. (2002) reported that the chicken TRPV1 channel differed in ~8 amino acids 
located in the third transmembrane domain compared to humans. The difference in this 
domain was found to be responsible for the insensitivity to capsaicin in chickens. 
Insensitivity to capsaicin has also been reported in reptiles and amphibians (Szallasi et al., 
1999; Hawkins et al., 1991). Functional TRPV1 proteins form as tetramers and exist as 
homo- or heteromultimers (Jordt et al., 2002). This tetramer protein structure may 
indicate that the inclusion of one of more TRPV1 SVs could affect the function of the 
channel. Furthermore, TRPV1 SVs in humans have been reported to form TRPV1 
channels which are not activated by capsaicin or protons (Lu et al., 2005).  Perhaps with 
less pressure to maintain conservation of functional TRPV1 channels for detection of 
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capsaicin avian TRPV1 mRNA is more likely to undergo AS without possible detrimental 
results from unproductive SVs. These data may also suggest that the AS of avian TRPV1 
is more likely to occur in certain tissue types based on the high frequency of TRPV1 AS 
found in the liver as compared to the brain.  
The correlation between the AS of POLB and lifespan in non-mammals  
 Finally, the AS of POLB in both tissue types for all four non-mammals 
investigated did not correlate well with lifespan. Unlike the strong positive correlation 
between POLB SV frequency reported in primates (Skandalis et al., 2010), non-
mammalian vertebrates did not show a correlation between an increase in POLB SV 
frequency and lifespan. These data suggest that the mechanisms in primates which 
generate POLB SVs are different than ones used by non-mammalian vertebrates.  
 The results in this chapter agree with previous data found in primates that showed 
most POLB SV types are not conserved among species and contain PTCs (Skandalis et 
al., 2010). No single type of POLB SV was found throughout all non-mammalian species. 
However, the exon two skip event was present in SVs from three out of the four species 
in this chapter.  
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CONCLUSIONS 
 
 The data presented in this chapter do not support the hypothesis that a positive 
correlation between POLB SV frequency and lifespan exists for non-mammalian 
vertebrates. This was the first work done on the AS of POLB in non-mammals and it 
revealed that SV frequencies and transcript diversities of POLB were low in these species 
compared to primates. Interestingly, the exon two skip AS event appeared to be 
conserved in the majority of vertebrate species. Tissue specific POLB AS was observed 
in the gull and the bearded dragon.  
 Comparison with a second gene, TRPV1 suggested that no increase or decrease of 
AS was present in specific tissues in the chicken whereas an increase in AS of both genes 
was observed in the frog brain compared to liver tissue. While non-mammalian 
vertebrates produced non-functional POLB SVs, similar to primates, the SVs occurred at 
lower frequencies and with less transcript diversity. Taken together, these results 
indicated that the mechanism for AS of POLB in primates that produced non functional 
POLB SVs at higher frequency in correlation with a longer lifespan in primates was not 
present in non-mammalian vertebrates.  
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CHAPTER THREE: Alternative splicing of POLB in mammalian tissues and cell 
lines  
Goal of Chapter three 
 
  The major goal of chapter three was to compare the AS patterns of POLB in 
mammalian tissues to those observed in cell lines. Previous literature has shown that in 
untransformed human fibroblasts POLB SV frequency and diversity are 57.4% and 14, 
respectively (Skandalis et al., 2010).  In conjunction with the AS patterns of POLB in 
humans and four other primate species, P.  pygmaeus, G. gorilla, P. troglodytes and M. 
fascicularis, Skandalis et al. (2010) revealed a positive correlation between POLB SV 
frequency and lifespan. What remains to be determined is if the AS patterns of POLB are 
consistent in mammalian tissues versus untransformed fibroblast cell lines. To address 
this, the POLB SV frequency and transcript diversity was compared in human liver and 
brain tissues to human cell lines. Furthermore, a comparison was done between 
mammalian and non-mammalian liver and brain tissues to examine whether a positive 
correlation between POLB SV frequency and lifespan exists in vertebrate species.  
 Similar to chapter two this chapter examined tissue specific AS patterns of POLB 
as well as using a second gene, TRPV1, to investigate possible tissue specific or gene 
specific changes in AS in specific tissue types.  
This chapter will explore three major hypotheses. First, I hypothesized that the AS 
patterns of POLB are consistent in human fibroblast cell lines to patterns observed in 
RNA isolated from human liver and brain tissues. Secondly, I hypothesized that the 
POLB SV frequency in mammalian tissues and primate cell lines, positively correlate 
with species lifespan. Finally, I hypothesized that a positive correlation between POLB 
SV frequency and lifespan will be seen in all vertebrate species studied here. 
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INTRODUCTION 
 
 Numerous approaches to explore AS have been employed which utilize in vivo, in 
vitro and computational bioinformatics systems (Florea 2005). There are advantages and 
disadvantages to each approach which can influence the AS patterns observed in each 
system. For example, EST studies which evaluate AS can only use the data available in 
databases, such as GeneBank and the Alternative Splicing Database. This could result 
either in an over or underestimation of AS frequencies, SV diversities, the types and AS 
events and their frequencies (Martin et al., 2011; Filichkin et al., 2010; Koralewski et al., 
2010; Gaidatzis et al., 2009). This matter has initiated comparative studies which evaluate 
AS data collected from different systems (Wang et al., 2008; Möröy T. et al., 2007; Kim 
et al., 2006; Helfman et al., 1998).  This chapter focuses on comparing the AS patterns of 
POLB in mammalian tissues and cell lines.  
 Generally, AS has been studied best using cell lines (Li et al., 2006). One reason 
for this trend is that cell lines generally represent a single cell type which provides a 
higher degree of reproducibility (Fedoroff et al., 2001). This is difficult to obtain through 
use of tissues, which often contain many cell types. Experimental conditions during cell 
culture can be tightly controlled allowing little to no variation in energy availability, 
growth factor levels and oxygen exposure. Another advantage to cell lines is a 
considerable decrease in cost. The cost of using animals for experimental work is very 
high in comparison to cell lines. In addition to the high cost of maintaining animals for 
experiments other concerns, such as ethical issues, are not applicable when working with 
cell lines. Tissue collection can be costly even if whole animals are not required. For 
instance, obtaining tissue samples from endangered species is sometimes impossible, but 
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acquiring cell lines is not out of the question. The living conditions and experiences of 
the animal prior to the point of sampling may also affect the AS patterns of the organism.  
 There are proposed limitations to using cell lines for AS studies. For example, 
cells rarely exhibit in vivo phenotypes of similar cell types (Li et al., 2006; Kemp et al. 
2005).  Lu et al. (2006) reported unique AS events were seen in the same cell line when 
grown under different conditions (Li et al., 2006). In addition, Li et al. (2006) found that 
AS patterns in tumour tissues more closely resembled patterns seen in Matrigel-cultured 
cells as compared to flat dish-cultured cells. This was suggested to occur because 
Matrigel-cultured cells contain a media which closely resembles the complex 
extracellular environment found in in vivo, whereas flat-dish cultured cells do not (Li et 
al., 2006; Moghe et al., 1997).  
 Kemp et al. (2005) described differences between AS events in cell culture versus 
tissues from transgenic mice. In this study, cell culture provided an incomplete picture of 
transcriptional regulation as compared to eight tissue types (Kemp et al., 2005). 
Thompson et al. (2002) showed the POLB AS had the similar SV frequencies (~ 55%) 
and transcript diversities (~ 6) in bladder cancer tissues versus bladder cancer cell lines. 
Thompson et al. (2002) was the only study to date which investigated the AS patterns of 
POLB in the cell lines and tissues, however testing was only conducted in bladder cancer 
samples with <31 cloned transcripts characterized.  
 POLB AS data collected from cell lines have elucidated important features about 
the AS of this gene such as SV types, SV frequencies, and suggested function for several 
POLB SVs (Skandalis et al., 2010; Simonelli et al., 2009; Disher et al., 2007; Skandalis et 
al., 2004; Thompson et al., 2002). Skandalis et al., (2010, 2004) and Disher et al. (2007) 
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showed POLB AS patterns in human untransformed fibroblast cell lines demonstrated 
numerous POLB SV types and high POLB SV frequencies (44.2%-57.4%) compared to 
rat fibroblasts (~1%-3%). It is important to investigate whether similar POLB AS patterns 
are present in human liver and brain tissues. Similar AS patterns will help support the 
hypothesis that SVs seen in cell lines are representative of the organism as a whole. This 
issue will be addressed by comparing the AS patterns POLB reported in cell lines by 
Skandalis et al. (2010) to liver and brain RNA isolated from human tissues.  
 A second mammal, the rabbit, was used to determine whether POLB SV 
frequency and transcript diversity correlate to lifespan in other mammalian species, as 
previously reported for primate species (Skandalis et al., 2010). Skandalis et al. (2010) 
has previously suggested that this correlation does exist for mammals in general. The 
POLB AS data from rabbit tissues will contribute to a growing mammalian data 
collection.  
 Finally, mammalian POLB AS patterns from this chapter will be compared to the 
non-mammalian data reported in chapter two to test the hypothesis that a positive 
correlation between the AS of POLB and lifespan exists in vertebrates.  
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RESULTS 
 
AS of POLB in rabbit tissues 
 
 POLB cloned transcripts were successfully amplified from the rabbit liver and 
brain (Figure 3.1, lane 2 and Figure 3.2 lane 10). The resulting size of the PCR product 
for the rabbit tissues were approximately 965 bps (Table 1.1).  A total of 66 and 50 POLB 
transcripts were characterized from the rabbit liver and brain, respectively.  
 
 
Figure 3.1 POLB PCR products amplified from rabbit liver. Lane 1 shows the DNA size 
marker. Lane 2 shows successful amplification of POLB from cDNA from the rabbit liver 
using POLBuniF x R. Lane 3 shows successful amplification of POLB from cDNA from 
the rabbit liver using DEGPOLBF x R. 
 
 
Figure 3.2 POLB PCR products amplified from rabbit brain tissue. Lane 1 shows the 
DNA size marker. Lane 2 contains a positive control, in which rabbit liver colony 
template was used. Lane 10 shows successful amplification of POLB from cDNA from 
the rabbit brain. Lanes 3-9 show unsuccessful amplification of POLB from other cDNA 
from the rabbit liver.  
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AS of POLB in rabbit liver tissue 
 
 Of the 66 POLB transcripts characterized from the rabbit liver 13 were SVs. 
POLB SV frequency in the rabbit liver was found to be 19.7% with 8 unique transcripts 
(Table 3.3). The non-canonical transcript with the highest frequency was retention of 78 
bps of undetermined sequence which occurred at a frequency of 7.6% (4/66) (Figure 3.3). 
This retention was determined through restriction digest with EcoRI which showed 
approximately 78 extra bps (according to restriction digest gel electrophoresis) in the 
second half of the gene (exons 8-14). Sequencing of this transcript was unsuccessful 
despite repeated attempts.  
 Two types of SVs, Δ4-6 and Δ9, were found with a frequency of 3% (2/66) each 
(Figure 3.2 and 3.3). The Δ4-6 transcript contains a premature termination codon (PTC) 
in exon eight created by a multiple exon skip. The Δ9 POLB SV contained a PTC in exon 
ten. The remaining POLB SVs observed all occurred at a frequency of 1.52% (1/66) 
(Figure 3.3). These SVs were Δ4,5,9, Δ4-10, Δ11 and ∑pI9₉,Δ12,13 (Figure 3.4). The 
Δ4,5,9 SV is 207 bps less than the CT. Multiple exon skipping of exons four and five 
caused a PTC in exon six.  The Δ4-10 POLB SV is 435 bps less than the CT. The 
multiple exons four through ten skip did not disrupt the reading frame and there are no 
PTCs included in the mRNA due to the seven skipped exons. The Δ11 SV is missing 87 
bps due to the exon 11 skip, compared to the CT. The exon 11 skip did not cause a PTC 
in the transcript. Finally, a complex partial intron retention and multiple exon skip event 
was observed in the ∑pI9₉Δ12,13 POLB SV (Figure 3.4). The retention of nine bps of 
intron nine in addition with the exon 12 and 13 skipping did not cause a PTC in this 
transcript.  
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AS of POLB in rabbit brain tissue 
 
 Of the 50 POLB transcripts characterized from the rabbit brain ten were SVs. The 
POLB SV frequency in the rabbit liver was 20% with a transcript diversity of eight (Table 
3.1). The SVs which occurred with the highest frequency, at 4.0% (2/50), were Δ2,9, 
Δ2,12, and Δ4,5 (Figures 3.3 and 3.4). The Δ2,9 and Δ2,12 SVs both contained PTCs in 
exon 3 due to exon 2 skip. The Δ4,5 POLB SV is 134 bps compared to the CT sequence 
due to the multiple exon four and five skip. This splicing event causes a PTC in exon six.  
 The remaining POLB SVs characterized in the rabbit brain occurred at 
frequencies of 2.0% (1/50) (Figure 3.3). These SVs were Δ2,11, Δ9, Δ9,11 and ∆12,13 
(Figure 3.4). The skipping of exon nine caused a PTC in affected transcripts in exon ten. 
There was no statistically significant difference in POLB SV frequencies between the 
rabbit liver and brain (x
2
=0.0016, d.f=1, p=0.9677, α=0.05). 
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Figure 3.3 POLB CT and SV frequencies of the liver and brain tissues in the rabbit. 
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Figure 3.4 POLB transcript types characterized from the liver and brain tissues of the 
rabbit. * Indicates location of a PTC.  
 
 
 
Table 3.1 POLB frequency of AS and transcript diversity in rabbit liver and brain tissues. 
 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity 
in tissue 
type 
Liver  Canonical transcript 53 
19.7 8 
 Splice variant  13 
Brain Canonical transcript 40 
20.0 8 
 Splice variant  10 
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AS of POLB in human tissues 
 
 POLB cloned transcripts were successfully amplified from human liver and brain 
total RNA (Figure 3.5, lane 8 and Figure 3.6 lanes 2-5). The resulting size of the PCR 
product for the human liver was approximately 1121 bps (Table 1.1).  A total of 153 and 
96 POLB transcripts were characterized from the human liver and brain, respectively.  
 
Figure 3.5 POLB PCR products amplified from human liver. Lane 1 shows the DNA size 
marker. Lane 2 shows unsuccessful POLB amplification from human liver cDNA using 
POLBuniF x R. Lane 3 contains a negative control, in which no cDNA was added to the 
reaction mixture, but water was. Lane 4 contains a second negative3 control, in which 
rabbit liver cDNA was used with human POLB primers, POLBfor1 x POLBrev1. Lanes 5 
and 8 show successful amplification of POLB from human liver cDNA. Lane 6 shows 
successful amplification of POLB from human breast tumor cDNA, which was not used 
in this work. Lane 7 and 9 show successful amplification of POLB from human fibroblast 
cell lines, as a positive control.  
 
 
 
Figure 3.6 POLB PCR products amplified from human brain. Lane 1 shows the DNA 
size marker. Lanes 2-5 show POLB PCR product from the human brain tissue. Lane 6 
contains a negative control, where water was used in place of template.  
 
 
1000 bps 
1000 bps 
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AS of POLB in human liver tissue 
 
 Of the 153 POLB transcripts characterized from the human liver 100 were SVs. 
The POLB SV frequency in the human liver was found to be 65.4% (Table 3.2). The 
POLB transcript diversity of the human liver was 18 (Table 3.2). The 17 types of SVs 
that were observed in this tissue showed simple and complex splicing events, including 
partial intron retention, single exon skipping, multiple exon skipping and partial intron 
retention along with single/multiple exon skipping.  
 The POLB SV which was observed with the highest frequency in the human liver 
was the Δ2 SV (Figure 3.7). This SV contained a PTC in exon 3 due to exon 2 skipping. 
This SV occurred with equal frequency with the CT at 34.4% (53/153) (Figure 3.9). The 
SV which occurred with the second highest frequency at 5.8% (9/153), was the POLB 
Δ11 SV (Figures 3.7 and 3.9). This SV did not contain a PTC as a result of exon 
skipping.  
 A single partial intron retention event was observed in the human liver. The 
partial intron retention event observed was the retention of 105 bps from intron six, 
referred to here as Σα (Figure 3.7). The inclusion of Σα does not disrupt the reading frame 
of the POLB transcript. This SV occurred at a frequency of 3.3% (5/153) (Figure 3.9).  
 Three other SVs were found all with a frequency of 3.3% (5/153): Δ2,4, Δ2,11, 
and Δ2,4-6 (Figures 3.7 and 3.9). Similar to all other POLB SVs with exon two skip and 
an intact exon three a PTC is created in exon three for all of these SVs.  
 Two POLB complex partial intron retention and single exon skip splicing events 
were observed in the human liver. The first was a SV which retained Σα and had exon 
two skip (Figure 3.7). This Σα, Δ2 SV had a PTC in exon three. The second complex 
103 
 
partial intron retention and single exon skip was the POLB SV Σα,Δ11 and it occurred at 
a frequency of 1.3% (2/153) (Figure 3.7 and 3.9). There was no PTC in this transcript as a 
result of the intron inclusion and exon skip.    
 Three POLB SVs were found to occur with a frequency of 1.3% (2/152); Δ2,5, 
Δ2,4-6,11, and Δ6,11 (Figures 3.7 and 3.9). The Δ2,5 and Δ2,4-6,11 SVs had PTCs in 
exon three due to exon two skip. Finally, the Δ6,11 SV contained a PTC in exon seven. 
 The final six POLB SVs observed in the human liver all occurred at a frequency 
of 0.65% (1/153) (Figure 3.9). These six SVs were ∆2,4,5, ∆2,4-6,9,11, ∆3-5,11, ∆4,5,11, 
∆5-10 and ∆12,13 (Figure 3.7). A PTC is created in exon three in the POLB SVs ∆2,4,5 
and ∆2,4-6,9,11. The ∆4,5,11 POLB SVs contained a PTC in exon six. Finally, the ∆3-
5,11, ∆5-10 and ∆12,13 SVs did not contain any PTCs due to the multiple exon skipping 
splicing events.  
AS of POLB in human brain tissue 
 
 Of the 96 POLB transcripts characterized from the human brain 88 were SVs. The 
POLB SV frequency in the human brain was found to be 91.7% (Table 3.2). The POLB 
transcript diversity of the human brain was 25 (Table 3.2). This tissue had the highest 
POLB SV frequency and diversity of any tissue investigated here in all species. Similar to 
the human liver, the types of splicing events seen in the human brain were composed of 
simple and complex intron retentions, single and multiple exon skipping. 
 Five of the POLB SV types found in the brain were previously observed in the 
human liver. These SVs included; Σα, Σα,Δ2, Δ2, Δ2,4-6,11, and Δ11 at frequencies of 
1.0% (1/96), 2.1% (2/96), 4.2% (4/96), 4.2% (4/96), 3.1% (3/96), and 3.1% (3/96), 
respectively (Figures 3.8 and 3.9). A POLB intron retention splicing event was seen in the 
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human brain. This SV occurred at a frequency of 1.1% (1/96) and retained 18 bps from 
intron eight, 108 bps from intron ten and had multiple exon skipping of exons 2,4-7,12, 
and 13 (Figures 3.8 and 3.9). Due to exon two skip the ∑p818, ∑p10108, Δ2,4-7,12,13 SV 
contained a PTC in exon three.  
 In addition to the SVs previously described in the human liver, ten SVs were 
found in the human brain which had exon two skipping with exon three intact. These 
transcripts and their frequencies were: Δ2,4-5,11-13 (1.0%) (1/96), ∆2,4-6 (16.7%) 
(16/96), ∆2,4-6,12,13 (1.0%) (1/96), ∆2,4-6,12 (3.1%) (3/96), Δ2,4-7,9 (2.1%) (2/96), 
Δ2,4-9,12 (7.3%) (7/96), Δ2,4-9,12,13 (6.3%) (6/96), Δ2,4-11 (3.1%) (3/96), ∆2,4-12 
(2.1%) (2/96), and Δ2,4-13 (22.9%) (22/96) (Figures 3.8 and 3.9). A PTC was present in 
exon three for these SVs.  
 Six POLB SVs in the human brain had multiple exon skips in the middle of the 
transcripts starting with the skip of exon two. These SVs and their frequencies were: Δ2-4 
(4.2%) (4/96), Δ2-5 (1.1%) (1/96), Δ2-7,9 (1.0%) (1/96), Δ2-9 (1.0%) (1/96), Δ2-9,11-13 
(2.1%) (2/96) and Δ2-13 (1.0%) (1/96) (Figures 3.8 and 3.9). A PTC was created in the 
SVs Δ2-4, Δ2-5, and Δ2-7,9 in exons five, six, and 11, respectively. Despite the > 8 exon 
skipping in the SVs Δ2-9, Δ2-9,11-13 and Δ2-13 no PTCs were present in these 
transcripts.  
 One POLB SV was found in the human brain which was also observed in the 
rabbit liver. This SV had exon 4-6 skipping and occurred at a frequency of 1.0% (1/96) 
(Figures 3.8 and 3.9). The Δ4-6 SV had a PTC in exon eight.  
 Finally, the last POLB SV found in the human brain was Δ11-13 and occurred at a 
frequency of 1.0% (1/96) (Figures 3.8 and 3.9). This SV did not contain any PTCs. There 
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was a statistically significant difference in POLB SV frequencies between human liver 
and brain (x
2
=22.0711, d.f=1, p=>0.0001, α=0.05). 
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Figure 3.7 POLB transcript types characterized from the human liver. * Indicates 
location of a PTC. 
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Figure 3.8 POLB transcript types characterized from the human brain. * Indicates 
location of a PTC. 
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Table 3.2 POLB frequency of AS and transcript diversity in human liver and brain. 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity 
in tissue 
type 
Liver  Canonical transcript 53 
65.4 18 
 Splice variant  100 
Brain Canonical transcript 8 
91.7 25 
 Splice variant 88 
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AS of TRPV1 in human tissues 
 
 TRPV1 cloned transcripts were successfully amplified from human liver and brain 
(Figures 3.10, lane 10 and 3.11, lane 2). The resulting size of the PCR product was 
approximately 2048 bps (Table 1.2). A total of 61 and 88 TRPV1 transcripts were 
characterized from the human liver and brain, respectively.  
 
Figure 3.10 TRPV1 PCR products amplified from human liver. Lane 1 shows the DNA 
size marker. Lane 2 contains a negative control where water was used in place of 
template. Lanes 3-9 show unsuccessful amplification of TRPV1 from the human liver 
using alternative TRPV1 primers. Lanes 10, 11 and 14 show TRPV1 PCR product from 
the human liver. Lanes 12, 13, and 15 show TRPV1 PCR product from the human 
untransformed fibroblast cell line, MRC5.  
 
  
Figure 3.11 TRPV1 PCR products amplified from human brain. Lane 1 shows the DNA 
size marker. Lanes 2-5 show TRPV1 PCR product from the human brain. 
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2000 bps 
111 
 
TRPV1 AS in human liver tissue 
 
 Of the 61 TRPV1 transcripts characterized from the human liver five were SVs. 
The TRPV1 SV frequency in the human liver was found to be 8.19% (Table 3.3). The 
TRPV1 transcript diversity of the human liver was three (Table 3.3).  
 The two TRPV1 SVs observed in the human liver tissue were ΣpI547 and Δ8 
(Figure 3.13). The ΣpI547 TRPV1 SV contained a partial 47 bp retention of intron five and 
occurred at a frequency of 4.9% (3/61) (Figure 3.12). This 47 bp inclusion resulted in a 
PTC in exon six. The TRPV1 Δ8 SV was lacking 180 bps compared to the canonical 
human TRPV1 transcript. This SV occurred at a frequency of 3.3% (2/61) in the human 
liver (Figure 3.12). No PTC was created from the skip of exon eight.  
TRPV1 AS in human brain tissue 
 
 Of the 88 TRPV1 transcripts characterized from the human brain four were SVs. 
The TRPV1 SV frequency in the human brain was 4.9% (3/61) (Table 3.3). The TRPV1 
transcript diversity of the human brain was four (Table 3.3). Two of the three TRPV1 SVs 
observed in the human brain were previously described in the human liver. These SVs 
were Σ547 and Δ8 which occurred at frequencies of 1.6% (1/61) and 2.3% (2/61), 
respectively in the human brain (Figures 3.12 and 3.13).  
  One TRPV1 SV was found only in the human brain, Δp8168,9,10,11,p1277, which 
occurred at a frequency of 1.6% (1/61) (Figures 3.12 and 3.13) . Due to the multiple 
partial and multiple full exon skipping events in this SV a PTC was created in exon 13. 
There was a statistically significant difference in TRPV1 SV frequencies between human 
liver and brain (x
2
= 0.8463, d.f=1, p=0.3576,α=0.05). 
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Figure 3.12 TRPV1 CT and SV frequencies of the human liver and brain. 
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Figure 3.13 TRPV1 transcript types characterized from the liver and brain of the human. 
 
 
 
 
 
 
 
 
 
 
Table 3.3 TRPV1 frequency of AS and transcript diversity in human liver and brain. 
Tissue 
type 
Type of transcript Number of 
transcripts 
found 
Splice variant 
frequency (%) 
Diversity 
in tissue 
type 
Liver  Canonical transcript 56 
8.19 3 
 Splice variant  5 
Brain Canonical transcript 84 
4.76 4 
 Splice variant  4 
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POLB and TRPV1 SV frequencies in the liver and brain of the human 
 
 There was a statistically significant difference found between POLB SV 
frequencies in human liver compared to human brain (x
2
:  57.0224, d.f=1, p=<0.0001, 
α=0.05). TRPV1 also showed a statistically significant difference between tissues types in 
both TRPV1 SV frequency and transcript diversity (x
2
: 139.3939, d.f=1, p=<0.0001, 
α=0.05).  
 
 
 
 
 
Figure 3.14 SV frequencies of POLB and TRPV1 in the human liver and brain. 
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POLB AS in human tissues as compared to human cell lines 
 
 In human untransformed fibroblast cell lines POLB SV frequency was reported to 
be 57.4% with a transcript diversity of 14 (Skandalis et al., 2010). Comparing this data to 
the human liver tissue there was no statistically significant difference found in POLB SV 
frequencies between cell lines and liver tissue (x
2=2.63, d.f=1, p=0.10, α=0.05) (Figure 
3.15). The human brain showed higher POLB SV frequencies than both human fibroblast 
cell lines and liver tissue (Figure 3.15).  
 POLB transcript diversity was lowest in cell lines with 14 different POLB 
transcripts types reported, compared to the 18 and 25 types observed in human liver and 
brain tissues, respectively (Figure 3.16).  
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Figure 3.15 POLB SV frequencies and transcript diversities in human untransformed 
fibroblast cell lines, human liver and brain tissues.  
 
 
 
Figure 3.16 POLB transcript diversities in human untransformed fibroblast cell lines, 
human liver and brain tissues.  
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AS of POLB in non-mammalian and mammalian species tissues 
 
 Non-mammalian tissues showed low AS of POLB compared to mammalian 
tissues in all tissue types. All non-mammalian species investigated here exhibited low 
POLB SV frequencies, <3.2% compared to mammalian species which showed moderate 
to high SV frequencies (19.7 - 91.7%).  
POLB AS and lifespan in mammals 
 
 Taken together, all known mammalian data including primate cell lines and 
gathered from rabbit and human brain tissue, POLB SV frequency and transcript diversity 
correlate strongly with log lifespan (frequency: R
2
=0.9223; diversity: R
2
=0.7031) (Figure 
3.17).  
 
Figure 3.17 Mammalian POLB SV frequencies, transcript diversity and log lifespan. 
Human and rabbit POLB SV frequency and transcript diversity data collected from brain 
tissue.  
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DISCUSSION 
 
 Analysis and comparison of the AS patterns of POLB in human tissues to human 
fibroblast cell lines revealed that liver tissues and cell lines showed similar POLB SV 
frequency, whereas brain tissue did not. POLB SV frequency and transcript diversity 
showed statistically significant differences between human liver and brain tissues. 
Moreover, the human brain tissue had the highest POLB SV frequency and transcript 
diversity of all vertebrate tissues, at 91.7% and 25, respectively.  Analysis of the AS 
patterns of the comparison gene, TRPV1 to POLB patterns indicated that there was no 
tissue specific overall increase or decrease of AS in either human liver or brain tissue. 
Finally, a positive correlation between POLB SV frequency and lifespan was observed in 
mammals but not in all vertebrates.    
AS patterns of POLB in rabbit liver and brain tissues 
 Rabbit liver and brain demonstrated similar POLB SV frequency, at 19.7% and 
20%, respectively, with no statically significant difference found between the two tissues. 
POLB transcript diversity was equal in these tissues with eight unique transcripts. Similar 
to non-mammals no statistically significant tissue specific POLB AS was found in the 
rabbit. These data, in conjunction with the POLB AS patterns in non-mammals suggests 
the AS of POLB is not tissue specific with regards to liver or brain tissues, for the 
majority of vertebrate species.  
 The common POLB AS events in the rabbit tissues were exon two or exon four 
skip in combination with additional exon skip. For example, exon two was often skipped 
in combination with exons 9, 11 or 12. Alternatively, exon four was skipped along with 
exons 5,6,7,8,9 and/or 10. It is interesting to note that the multiple exon skips involved 
with exon two only occurred in the rabbit brain whereas exon four skip events were seen 
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in both tissues. This is similar to non-mammal exon two skip events which were 
primarily observed in brain tissue. Exon two skip was the only POLB splicing event 
which appeared to be conserved throughout vertebrate species examined. The exon 11 SV 
was also recorded in rabbit tissues. This SV has been previously reported in human 
tissues and cell lines but this represents the first evidence of the event in non-mammals 
(Skandalis et al., 2010; Simonelli et al., 2009; Disher et al., 2007; Skandalis et al., 2004; 
Thompson et al., 2002). 
AS patterns of POLB in human liver and brain tissues 
 In human tissues POLB was alternatively spliced in a tissue specific manner. High 
SV frequencies were observed in the human brain compared to the liver, 91.7% versus 
65.4%, respectively. Transcript diversity was also higher in the human brain at 25 types 
compared to the liver which had 18. These tissues have the highest recorded POLB SV 
frequencies and diversities of all vertebrate species. Six POLB SVs were common to both 
liver and brain tissues in humans. These SVs were Σα, Σα,Δ2, Δ2, Δ2,4-6, Δ2,4-6,11 and 
Δ11. All of these SVs have been observed human cell lines previously (Skandalis et al., 
2010; Simonelli et al., 2009; Disher et al., 2007; Skandalis et al., 2004; Thompson et al., 
2002).  
POLB AS patterns in cell lines and tissues  
 The first hypothesis of this chapter was that POLB AS data collected from human 
fibroblast cell lines were consistent with RNA isolated from human tissues. The observed 
results do not agree with this hypothesis. Although the POLB SV frequencies between the 
human liver and fibroblast cell lines are similar the types observed are different. A large 
difference between POLB AS in the brain compared to cell lines was also observed, 
91.7% versus 57.4%. There were 17 novel POLB SVs characterized in human tissues 
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which had not been observed in human cell lines or tissues on previous occasions 
(Skandalis et al., 2010; Simonelli et al., 2009; Disher et al., 2007; Skandalis et al., 2004; 
Thompson et al., 2002). 
 There are several possibilities as to why these novel POLB SVs were present in 
tissues and yet not found in cell lines. First, cell type may have influenced the types of 
POLB SVs observed. If POLB AS is cell type specific perhaps different cell types 
produce specific SVs. Indeed, AS patterns of numerous genes have been shown to be cell 
type specific (Hanamura et al., 1998). Specifically, POLB has been shown to produce 
specific SV types between untransformed normal foetal lung fibroblast cells and 
transformed human lymphoblastoid cells (Disher et al., 2007). The results shown here 
demonstrate AS patterns of POLB do differ between cell lines and tissues. Moreover, 
tissue specific splicing patterns of POLB were observed in human tissues, which would 
not be represented in a single cell type analysis. These data indicate that cell lines do not 
represent the POLB splicing patterns in all human tissues.  
The Δ2 POLB SV in vertebrate tissues 
 The human liver showed equal frequencies of CT POLB and Δ2. If the SV 
frequencies found reflect the expression levels it could suggest that 50% of the POLB 
transcripts expressed in the liver are Δ2. The Δ2 variant is by far the most studied POLB 
SV. The Δ2 variant has been reported in five primate species, including humans as well 
as numerous human cell lines (Skandalis et al., 2010; Simonelli et al., 2009; Disher et al., 
2007; Skandalis et al., 2004; Thompson et al., 2002). This thesis is the first work to show 
that the Δ2 POLB SV is primarily found in brain tissue and not liver tissue for the 
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majority of vertebrate species, with the exception of humans. Human brain tissue showed 
Δ2 occurred at a frequency of 4.17%.  
 Simonelli et al., (2009) investigated Δ2 frequencies in various human tissues and 
suggest the skip of exon two observed was not tissue specific or disease related. The 
findings presented in this thesis suggest that exon two skip event is tissue specific, at least 
in the liver and brain tissues of non-mammals, gull, frog and bearded dragon and one 
mammal (rabbit). Whether the Δ2 variant is present in other tissues of non-mammals 
such as heart or muscle tissues is not known at this time. The question remains as to why 
it was observed in brain tissues and not liver in these species.   
 One possibility may be that the Δ2 SV plays a key role in the down regulation of 
normal POLB activity in the vertebrate brain. Studies have demonstrated that several 
tumour types over express POLB (reviewed by Starcevic et al., 2004), and that high 
levels of POLB destabilize some cellular processes that lead to tumour progression 
(Sweasy et al., 2003). Perhaps the expression of Δ2 functions to regulate the expression 
levels of POLB in the brain to counter tumourgenesis. Srivastava et al., (1998) showed 
that in mammals POLB protein is the rate limiting step of BER in vitro. Results in this 
chapter showed that Δ2 and CT POLB were present in the human brain. Based on this 
finding and considering that POLB is the rate limiting step in BER in mammals we may 
expect to find reduced BER in the human brain if Δ2 is acting to down regulate normal 
POLB expression. Lu et al. (2004) suggested that BER is in fact reduced in the human 
brain during aging, specifically in individuals over the age of 40. All of the donors of the 
pooled human brain RNA used in the work presented here were over the age of 40.  
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POLB frequency and transcript diversity was highest in human brain tissue  
 Considering the ages of donors of the human RNA the reason why POLB SVs 
levels exist in the brain could simply be a result of advanced age. The AS of certain genes 
has been shown to increase with age in humans (Tollervey et al., 2011). A future 
investigation examining the SV frequencies, types and expression levels of POLB SVs in 
individuals of different ages in multiple tissue types would be a very informative.  
 Another possibility for high POLB SV frequency and transcript diversity in the 
human brain is the circumstances of the RNA isolation.  Awasthi et al. (1997) observed 
that oxidative stress significantly increased in rat brains within 60 minutes following 
brain injury. Similar increases in oxidative stress following brain injury have been 
reported in humans (Clausen et al., 2011). If trauma occurred to the brain prior to RNA 
isolation the effects of increased oxidative stress may have influenced AS patterns of 
genes in this tissue. Oxidative stress has been demonstrated to affect the AS of POLB 
(Disher et al., 2007). Disher et al. (2007) observed that under oxidative stress the overall 
frequency of POLB SVs increased in both untransformed normal foetal lung fibroblast 
cells and transformed human lymphoblastoid cells. It could be possible that the high 
POLB SV frequency and transcript diversity observed in the human brain was a result of 
an increase in oxidative stress in donor brain tissue.  
 Finally, POLB SV frequencies may have been higher in human brain tissues as 
compared to liver tissue because the human brain has a higher overall SV frequency. This 
higher SV frequency could apply to all genes in the brain or perhaps just DNA repair 
genes. In humans, out of several tissue types, liver and brain tissues showed the highest 
levels of AS at 42% and 39%, respectively (Yeo et al., 2004). This analysis was based on 
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the number of genes which showed one or more AS event. Although Yeo et al. (2004) 
indicated that the number of genes which undergo AS was highest in the human brain, 
they did not report the SV frequencies. If SV frequencies are higher for all genes in the 
brain, additional genes besides POLB should show high SV frequencies when compared 
to liver tissues. To investigate this in human liver and brain tissues POLB SV frequencies 
were compared to a second gene, TRPV1. Results showed that TRPV1 SV frequency and 
transcript diversity were higher in the liver compared to the brain suggesting the brain 
does not have overall higher AS frequencies with respect to POLB and TRPV1. It is 
possible that DNA repair genes have high AS frequencies in the human brain as 
compared to non-DNA repair genes like TRPV1. Future experiments could investigate the 
AS of a variety of DNA repair genes in different human tissues to see whether all DNA 
repair genes have high frequencies of AS or just POLB.  
AS of POLB, TRPV1 and a possible link through inflammation 
 It is possible that TRPV1 generally has a higher SV frequency in the liver tissue 
compared to the brain. Chicken liver tissue showed a very high level of TRPV1 splicing 
compared to the brain however; frog tissues demonstrated the opposite trend.  Taken 
together, these data suggest that POLB SV frequency and transcript diversity is high in 
the human brain compared to the human liver and it was not due to an overall systemic 
increase of AS in the tissue. Interestingly, two novel TRPV1 SVs out of the three SVs 
were observed in human tissues. The Δ8 TRPV1 SV, described by Lu et al. (2005) was 
named hTRPV1b. The hTRPV1b SV was shown to produce a functional protein which is 
activated by temperature but not capsaicin or protons (Lu et al., 2005). Unlike hTRPV1b 
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the two novel human TRPV1 SVs, Δp8168,9,10,11,p1277 and Σ547 both harbour PTCs in 
their transcripts. Whether these SVs have any obvious function is not known at this time.   
 TRPV1 was chosen as a comparison gene to POLB in this thesis based on 
considerations discussed in Chapter Two. However, there is a possible link between these 
two genes that is noteworthy. When tissue damage occurs signalling pathways are 
induced that trigger inflammation (Durnett, et al., 2002). In turn, an increase in 
inflammatory agents result in the direct activation of TRPV1 channels which cause 
TRPV1-mediated [Ca
2+
] to rise triggering a release of pro-inflammatory agents (Planells-
Cases et al., 2005). Inflammation induces oxidative stress by generating reactive oxygen 
species (ROS) (Bartsch et al., 2006; reviewed by Halliwell et al., 1996). DNA damage 
caused by ROS is well documented (reviewed by Cooke et al., 2003). The overall 
frequency of POLB SVs is increased in cells exposed to oxidative stress (Disher et al., 
2007). Given the inflammation and oxidative stress link between POLB and TRPV1 it 
would be intriguing to investigate the splicing patterns of the two genes during exposure 
to inflammation.  
POLB transcript diversity in mammals 
 POLB transcript diversity was higher in mammalian as compared to non-
mammalian tissues. There were 13 different POLB SVs types observed in the rabbit 
tissues and 34 types in the human tissues. The majority of human brain POLB SVs had 
exon two skip in combination with multiple other exon skips. Several of these POLB SVs 
were characterized with large portions of the gene skipped. Thompson et al. (2002) 
described POLB SVs with multiple exon skips, in some cases 12 out of 14 exons, in 
bladder tumour tissues.  Similar POLB SVs were observed in gastric cancer cell lines by 
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Simonelli et al. (2009). Why POLB displays these splicing patterns in this tissue is 
unknown. The presence of multiple exon skipping in mammalian verses non-mammalian 
POLB SVs agrees with previous findings suggesting that the occurrence of exon skipping 
increases further up the eukaryotic evolutionary tree (reviewed by Keren et al., 2010 and 
Kim et al., 2007).  
 Premature termination codons (PTCs) were found in all but one POLB SV in non-
mammals, with chicken liver tissues demonstrating the only POLB SVs without a PTC. 
In rabbit and human tissues 66.6% and 66.4% of the POLB SVs generated contained 
PTCs, respectively. PTCs have been observed in a considerable fraction of generated SVs 
and an estimated 12% of human genes which undergo AS have them (reviewed by 
Lareau et al., 2007). In some cases splicing errors, such as mutations in introns or 
incorrect recognition of splice sites by the splicing machinery, could result in the creation 
of a PTC in SV (Lareau et al., 2007). Alternatively, an estimated 66% of human genes 
which generate SVs containing a PTC are a result of a PTC specific splice site (Soergel 
2005). It has been suggested that SVs which contain a PTC could be functional and 
perhaps be conserved in a species specific manner (Kan et al., 2002).  Analyses by 
Skandalis et al. (2004) revealed that at least a portion of POLB SVs generated are a result 
of aberrant splicing. The evolutionary conservation of the Δ2 variant suggests that some 
of the POLB SVs containing PTCs are not subject to NMD. Moreover, the POLB SVs 
containing PTCs are perhaps selected by the cell to provide an additional level of 
regulation, for example as a micro-RNA precursor (Simonelli et al., 2009).   
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A positive correlation between POLB SV frequency and lifespan in mammals  
 Mammalian tissue data support the hypothesis that there is a positive correlation 
between POLB SV frequency and lifespan in mammals. This hypothesis agrees with the 
findings reported in primate species and mammals in general as suggested by the 
Skandalis et al. (2010) (unpublished). These data suggest that as lifespan of a species 
increases the POLB SV frequency and transcript diversity does as well. The mechanism 
behind this correlation has been proposed to involve down-regulation of gene expression 
(Skandalis et al., 2010) so perhaps this results in a reduction in CT POLB synthesis.  
 Interestingly, Brown et al. (2007) observed a negative correlation between POLB 
protein activity and species maximum lifespan in mammalian primary dermal fibroblasts 
under atmospheric oxygen. Although the reported increase in POLB SVs and a decrease 
in POLB activity with lifespan of a species (Brown et al., 2007) cannot be definitively 
linked to the AS of POLB without expression levels of POLB transcripts, (both CT and 
SVs) these results may indicate a general trend is present in mammals. Additionally, 
oxygen conditions of the fibroblast cell lines were shown to influence POLB activity 
(Brown et al., 2007) which further demonstrates the importance of cell line and tissue 
comparison experiments. Furthermore, it was proposed by Page et al. (2011) that the 
relationships between BER and lifespan may be cell type specific.  
 Particular POLB SVs are suggested to act as dominant negative regulators of 
normal POLB activity (Thompson et al., 2002) and it was demonstrated that high levels 
of POLB destabilize further cellular processes and in turn lead to tumour progression 
(Sweasy et al., 2003). Perhaps some POLB SVs, such as Δ2 and Δ11, have functional 
roles without forming functional protein but, we must ask, what about the remainder of 
127 
 
the SVs? Moreover, why would AS of POLB correlate to a longer lifespan when POLB 
functions as a DNA repair protein? Perhaps the process of generating POLB SVs alone is 
related to lifespan and not the production of specific SVs themselves, as suggested by 
Skandalis et al. (2010). With analysis of only two mammalian species it is difficult to 
determine whether particular POLB SVs are evolutionary conserved in mammals, apart 
from Δ2.  However, in addition to Δ2 four other POLB SVs were observed in both rabbit 
and human tissues, Δ2,11, Δ4-6, Δ11 and Δ12,13. Future experiments could focus on an 
investigation of these four SVs in other mammalian tissues. The conservation of these 
SVs could suggest a functional role for them in mammals.  
 The final proposed hypothesis was that a positive correlation existed between the 
AS of POLB and lifespan in vertebrate species in general. Data gathered from four non-
mammalian and two mammalian species taken together with observations in primate cell 
lines did not support this hypothesis. Instead, these data suggest that a positive correlation 
exist in mammals and not in non-mammals.  
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CONCLUSIONS 
 
 The AS patterns of POLB in mammals showed that liver and brain tissues had 
higher SV frequency and transcript diversity compared to non-mammalian tissues. The 
AS of POLB was found to be tissue specific in human liver and brain whereas in rabbit 
tissues it was not. There were 17 novel POLB SVs in human tissues which had not been 
described previously. Additionally, all the POLB SVs characterized in rabbit tissues have 
not been reported prior to this work. The human brain demonstrated the highest POLB 
SV frequency and transcript diversity in all vertebrate species investigated. Investigation 
of the AS patterns of a second gene TRPV1, suggests that the POLB AS patterns observed 
are not a result of an overall increase in AS in the liver or brain tissues of mammals. The 
positive correlation between the AS of POLB and lifespan previously reported in 
primates appears to exist in all mammals. However, taken together with non-mammalian 
POLB AS patterns a positive correlation does not appear to exist in all vertebrates.  
 
 
 
 
 
 
 
 
 
129 
 
General conclusions and further directions 
 
 The main objective of this work was to investigate AS of the DNA polymerase 
gene, POLB, in vertebrates. Previous work demonstrates that a positive correlation 
between POLB SV frequency and lifespan exists in primate cell lines (Skandalis et al., 
2010). Whether this positive correlation exists in all vertebrates is unknown. This work 
aimed to explore said correlation. Does this positive correlation exist in non-mammals? 
Do human cell lines reflect the AS patterns of POLB seen in human tissues? Is the AS of 
POLB representative of the SV frequencies of other genes such as non-DNA repair 
genes?  
 To answer these questions, four non-mammalian species were selected: the 
chicken, gull, frog and bearded dragon, as well as two mammalian species: the rabbit and 
human. POLB transcripts were characterized in liver and brain tissues from 
aforementioned vertebrate species to determine POLB SV frequency and transcript 
diversity.  
 The second chapter of this thesis revealed that AS of POLB in non-mammalian 
tissues was low, both in frequency and transcript diversity, compared to observations 
made in primate cell lines. In terms of liver and brain tissues, statistically significant 
differences in POLB SV frequency were found in the bearded dragon and gull but not in 
chicken and frog. Analysis of the comparison gene, TRPV1, suggested that POLB was not 
subject to an overall increase or decrease of AS within particular tissues. Comparing 
POLB SV frequency with lifespan revealed that a positive correlation between the AS of 
POLB and lifespan did not exist in non-mammalian tissues. Finally, the skip of exon two 
in various forms was observed in three out of four species but only in brain tissues.  
130 
 
 The third chapter of this thesis investigated the AS of POLB in mammals and cell 
lines. POLB SV frequency was similar in human liver tissue compared with cell lines, 
while transcript diversities were not. The human brain showed significantly higher POLB 
SV frequency and transcript diversity than cell lines. While it appears that human 
untransformed fibroblast cell lines may be an appropriate representation for some human 
tissues, they show an underestimation of POLB AS for others. TRPV1 analysis suggested 
that there was no overall increase or decrease in AS in liver or brain tissues of humans, 
which would have affected the AS patterns of POLB. Tissue specific AS of POLB 
seemed to exist in human tissues and not in rabbit tissues.   
 Finally, the data in chapters two and three suggest that a positive correlation 
between the AS of POLB and lifespan exists in mammals but not all vertebrates. Data 
from the investigation of POLB protein activity in mammals showed a decrease in POLB 
activity in mammalian species with longer lifespan. This may suggest that the decrease in 
POLB DNA repair capacity results from the increase in POLB SVs in mammals (Brown 
et al., 2007). Furthermore, Page et al. (2011) did not find that the increase in POLB 
activity in brain or liver tissues of vertebrate species evolved with lifespan. Perhaps the 
decrease in POLB activity is a result of increased unproductive POLB SV production. 
Such a relationship could be connected to lifespan in mammals, but not non-mammals, 
and therefore not in vertebrates as a whole. To investigate this relationship, expression 
levels of POLB CT and SV transcripts could be collected and examined to elucidate the 
connection between the production of SVs and protein expression.  
 There are several avenues of research to investigate that could be investigated to 
continue the work presented in this thesis. For example, although POLB is evolutionary 
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conserved at the nucleotide level, mutations may be present in splice sites of non-
mammals as compared to mammals. If there are changes in the splice sites this presents a 
possible explanation for the low POLB SV frequency observed in non-mammals. 
Bioinformatic analyses of the splice sites of POLB from numerous vertebrates would be 
the first step to elucidate this possibility.  
 In terms of tissue collection, each species was represented by a single organism 
with the exception of the human brain. In the case of the human brain, RNA was isolated 
and pooled from 12 individuals. Expanding the investigation to more individuals of each 
species should reveal variations within POLB SV between individuals. Furthermore, 
RNA isolation from distinct human brain tissue samples should be collected. This would 
allow data from these samples to be compared to human pooled brain RNA data to help 
elucidate possible variations in AS patterns of POLB present between individuals.  
 Investigating the expression levels of POLB SVs in tissues would be incredibly 
useful for understanding the AS of POLB. The presence and frequencies of POLB SVs 
alone are not enough to indicate their expression levels. Using quantitative PCR to 
measure the expression levels of each SV would indicate whether POLB SVs are 
significant enough to influence the overall DNA repair capacity of normal POLB.  
Despite the considerable time and effort required to accomplish such a task, results would 
provide valuable insight into the AS of POLB in vertebrates.  
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